293SLAM rinderpest infection, 00hr, biol_rep1 | 13541-145H4 |
309.74 | 246.23 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 00hr, biol_rep2 | 13542-145H5 |
308.94 | 243.59 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 00hr, biol_rep3 | 13543-145H6 |
365.94 | 269.87 | 0.58 | 0.00 | 0.19 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 06hr, biol_rep1 | 13544-145H7 |
283.59 | 226.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 06hr, biol_rep2 | 13545-145H8 |
307.53 | 255.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 06hr, biol_rep3 | 13546-145H9 |
305.83 | 251.95 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 12hr, biol_rep1 | 13547-145I1 |
484.57 | 399.82 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 12hr, biol_rep2 | 13548-145I2 |
362.84 | 312.71 | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 12hr, biol_rep3 | 13549-145I3 |
308.61 | 261.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 24hr, biol_rep1 | 13550-145I4 |
291.55 | 127.52 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 24hr, biol_rep2 | 13551-145I5 |
238.50 | 104.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
293SLAM rinderpest infection, 24hr, biol_rep3 | 13552-145I6 |
209.37 | 101.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1 | 13625-146H7 |
184.57 | 66.41 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2 | 13626-146H8 |
210.79 | 73.67 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3 | 13627-146H9 |
190.57 | 72.67 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1 | 13628-146I1 |
174.28 | 70.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2 | 13629-146I2 |
175.38 | 73.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3 | 13630-146I3 |
164.93 | 79.30 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1 | 13631-146I4 |
189.27 | 72.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2 | 13632-146I5 |
227.62 | 90.42 | 0.15 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3 | 13633-146I6 |
227.88 | 82.73 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1 | 13634-146I7 |
254.10 | 97.70 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2 | 13635-146I8 |
211.85 | 85.18 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3 | 13636-146I9 |
203.84 | 82.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1 | 13637-147A1 |
185.75 | 85.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2 | 13638-147A2 |
198.14 | 74.38 | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3 | 13639-147A3 |
207.15 | 98.35 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1 | 13640-147A4 |
240.23 | 83.69 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2 | 13641-147A5 |
193.83 | 73.82 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3 | 13642-147A6 |
216.07 | 76.73 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1 | 13643-147A7 |
224.84 | 86.67 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2 | 13644-147A8 |
179.36 | 72.10 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3 | 13645-147A9 |
197.31 | 77.45 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1 | 13646-147B1 |
366.83 | 136.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 13647-147B2 |
216.53 | 82.28 | 0.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 13648-147B3 |
184.53 | 64.58 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 13649-147B4 |
208.26 | 74.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 13650-147B5 |
194.23 | 72.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 13651-147B6 |
233.37 | 80.76 | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 13652-147B7 |
222.54 | 75.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 13653-147B8 |
191.97 | 67.05 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 13654-147B9 |
262.92 | 105.40 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 13655-147C1 |
198.24 | 75.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 13656-147C2 |
188.64 | 68.01 | 0.17 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 13657-147C3 |
204.79 | 79.31 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 13658-147C4 |
197.52 | 81.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 13659-147C5 |
161.94 | 63.58 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 13660-147C6 |
208.93 | 87.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1 | 13661-147C7 |
148.17 | 63.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 13662-147C8 |
186.22 | 77.24 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 13663-147C9 |
174.62 | 76.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 13664-147D1 |
167.89 | 72.27 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2 | 13665-147D2 |
1595.11 | 699.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3 | 13666-147D3 |
130.94 | 53.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1 | 13667-147D4 |
149.45 | 50.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2 | 13668-147D5 |
755.88 | 307.89 | 3.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 13669-147D6 |
370.61 | 141.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1 | 13670-147D7 |
104.69 | 39.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2 | 13671-147D8 |
91.21 | 32.44 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3 | 13672-147D9 |
250.52 | 116.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2 | 13674-147E2 |
90.25 | 36.66 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3 | 13675-147E3 |
121.69 | 33.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 13676-147E4 |
224.51 | 99.52 | 4.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2 | 13677-147E5 |
167.85 | 69.31 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 13678-147E6 |
76.68 | 27.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1 | 13679-147E7 |
57.51 | 28.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2 | 13680-147E8 |
937.51 | 290.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3 | 13681-147E9 |
1002.98 | 323.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 13682-147F1 |
66.79 | 34.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2 | 13683-147F2 |
65.46 | 36.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3 | 13684-147F3 |
46.91 | 32.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1 | 13685-147F4 |
78.16 | 56.96 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2 | 13686-147F5 |
73.93 | 39.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3 | 13687-147F6 |
67.57 | 30.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor1 | 11376-118A8 |
147.46 | 156.64 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - breast, donor2 | 11327-117E4 |
243.21 | 217.38 | 0.48 | 0.32 | 0.16 | 0.00 | 0.00 | 0.00 |
Adipocyte - omental, donor1 | 11473-119C6 |
215.40 | 263.23 | 0.51 | 0.13 | 0.13 | 0.00 | 0.00 | 0.00 |
Adipocyte - omental, donor2 | 11474-119C7 |
180.15 | 159.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - omental, donor3 | 11475-119C8 |
293.05 | 261.24 | 1.00 | 1.00 | 0.67 | 0.00 | 0.00 | 0.00 |
Adipocyte - perirenal, donor1 | 11476-119C9 |
217.55 | 167.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - subcutaneous, donor1 | 11259-116F8 |
263.88 | 258.38 | 0.00 | 0.00 | 1.10 | 0.00 | 0.00 | 0.00 |
Adipocyte - subcutaneous, donor2 | 11336-117F4 |
212.26 | 162.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte - subcutaneous, donor3 | 11408-118E4 |
297.85 | 129.64 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day04, donor1 | 13019-139D4 |
202.42 | 132.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day04, donor2 | 13022-139D7 |
145.93 | 89.57 | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day04, donor3 | 13025-139E1 |
212.42 | 126.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day04, donor4 | 13028-139E4 |
186.34 | 103.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day08, donor1 | 13020-139D5 |
339.99 | 275.89 | 0.08 | 0.08 | 0.16 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day08, donor2 | 13023-139D8 |
177.84 | 142.98 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day08, donor3 | 13026-139E2 |
205.28 | 138.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day08, donor4 | 13029-139E5 |
198.65 | 194.20 | 0.00 | 0.00 | 0.56 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day12, donor1 | 13021-139D6 |
235.39 | 200.04 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day12, donor2 | 13024-139D9 |
167.28 | 167.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day12, donor3 | 13027-139E3 |
199.29 | 166.57 | 0.00 | 0.00 | 0.33 | 0.00 | 0.00 | 0.00 |
Adipocyte differentiation, day12, donor4 | 13030-139E6 |
141.27 | 151.02 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Alveolar Epithelial Cells, donor1 | 11510-119G7 |
92.38 | 48.40 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 |
Alveolar Epithelial Cells, donor2 | 11590-120G6 |
16.49 | 6.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Alveolar Epithelial Cells, donor3 | 11671-122G6 |
28.75 | 4.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Amniotic Epithelial Cells, donor1 | 11533-120A3 |
43.18 | 17.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Amniotic Epithelial Cells, donor2 | 11613-122A2 |
25.10 | 11.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Amniotic Epithelial Cells, donor3 | 11694-123A2 |
32.87 | 12.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Anulus Pulposus Cell, donor1 | 11248-116E6 |
465.03 | 150.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Anulus Pulposus Cell, donor2 | 11463-119B5 |
321.81 | 75.43 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1) | 12642-134G5 |
221.05 | 151.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2) | 12740-135I4 |
240.95 | 145.44 | 0.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3) | 12838-137B3 |
186.20 | 126.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4) | 12643-134G6 |
234.35 | 139.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5) | 12741-135I5 |
264.31 | 177.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6) | 12839-137B4 |
211.22 | 110.23 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7) | 12644-134G7 |
212.80 | 124.11 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8) | 12742-135I6 |
202.91 | 136.41 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9) | 12840-137B5 |
221.52 | 130.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10) | 12645-134G8 |
248.96 | 141.62 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 12743-135I7 |
211.90 | 116.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12) | 12841-137B6 |
181.80 | 121.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13) | 12646-134G9 |
235.90 | 141.01 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14) | 12744-135I8 |
199.26 | 150.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15) | 12842-137B7 |
207.19 | 118.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 12647-134H1 |
218.07 | 136.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17) | 12745-135I9 |
230.50 | 121.49 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18) | 12843-137B8 |
233.61 | 133.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 12648-134H2 |
179.48 | 106.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 12746-136A1 |
231.37 | 119.92 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21) | 12844-137B9 |
190.91 | 116.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22) | 12649-134H3 |
177.01 | 123.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23) | 12747-136A2 |
219.39 | 100.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24) | 12845-137C1 |
251.70 | 125.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25) | 12650-134H4 |
215.53 | 155.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 12748-136A3 |
279.28 | 121.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27) | 12846-137C2 |
202.30 | 125.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28) | 12651-134H5 |
200.08 | 156.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29) | 12749-136A4 |
212.06 | 105.60 | 0.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30) | 12847-137C3 |
183.24 | 99.11 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31) | 12652-134H6 |
189.56 | 114.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32) | 12750-136A5 |
209.33 | 109.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33) | 12848-137C4 |
236.15 | 131.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34) | 12653-134H7 |
210.58 | 112.31 | 1.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35) | 12751-136A6 |
234.23 | 121.03 | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36) | 12849-137C5 |
215.03 | 109.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37) | 12654-134H8 |
233.43 | 152.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38) | 12752-136A7 |
254.94 | 134.22 | 0.25 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39) | 12850-137C6 |
199.51 | 113.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40) | 12655-134H9 |
224.40 | 126.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41) | 12753-136A8 |
232.22 | 119.60 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42) | 12851-137C7 |
188.20 | 103.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43) | 12656-134I1 |
196.51 | 107.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44) | 12754-136A9 |
221.74 | 100.02 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45) | 12852-137C8 |
192.26 | 127.40 | 4.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46) | 12657-134I2 |
207.03 | 158.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47) | 12755-136B1 |
225.78 | 101.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48) | 12853-137C9 |
212.39 | 129.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49) | 12658-134I3 |
247.12 | 137.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50) | 12756-136B2 |
256.55 | 120.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51) | 12854-137D1 |
219.33 | 112.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52) | 12659-134I4 |
232.37 | 142.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53) | 12757-136B3 |
239.68 | 118.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54) | 12855-137D2 |
171.36 | 106.18 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55) | 12660-134I5 |
221.32 | 135.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56) | 12758-136B4 |
201.56 | 112.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57) | 12856-137D3 |
212.09 | 125.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58) | 12661-134I6 |
203.83 | 135.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59) | 12759-136B5 |
187.21 | 100.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60) | 12857-137D4 |
195.90 | 82.50 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Astrocyte - cerebellum, donor1 | 11500-119F6 |
114.10 | 75.29 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Astrocyte - cerebellum, donor2 | 11580-120F5 |
38.51 | 16.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Astrocyte - cerebellum, donor3 | 11661-122F5 |
29.15 | 9.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Astrocyte - cerebral cortex, donor1 | 11235-116D2 |
488.72 | 356.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Astrocyte - cerebral cortex, donor2 | 11316-117D2 |
439.38 | 301.38 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Astrocyte - cerebral cortex, donor3 | 11392-118C6 |
457.62 | 237.31 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1 | 10821-111C2 |
756.58 | 247.84 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2 | 10822-111C3 |
704.58 | 276.62 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3 | 10823-111C4 |
750.15 | 285.40 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Basophils, donor1 | 12241-129G9 |
61.98 | 11.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Basophils, donor2 | 12242-129H1 |
220.45 | 31.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Basophils, donor3 | 12243-129H2 |
74.23 | 9.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor1 | 11511-119G8 |
42.47 | 18.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor2 | 11591-120G7 |
10.06 | 2.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor3 | 11672-122G7 |
365.85 | 157.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor4 | 11453-119A4 |
326.38 | 229.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor5 | 11457-119A8 |
103.98 | 55.94 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor6 | 11461-119B3 |
196.67 | 42.37 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bronchial Epithelial Cell, donor7 | 11769-123I5 |
366.55 | 144.14 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Burkitt's lymphoma cell line:DAUDI | 10422-106C8 |
711.39 | 296.59 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Burkitt's lymphoma cell line:RAJI | 10476-106I8 |
1474.75 | 585.05 | 0.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD133+ stem cells - adult bone marrow derived, pool1 | 12224-129F1 |
855.08 | 285.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD133+ stem cells - cord blood derived, pool1 | 12223-129E9 |
1406.50 | 268.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ Monocytes, donor1 | 11224-116B9 |
98.06 | 12.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ Monocytes, donor2 | 11305-117B9 |
103.19 | 8.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ Monocytes, donor3 | 11381-118B4 |
98.79 | 10.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocyte derived endothelial progenitor cells, donor1 | 11229-116C5 |
148.03 | 71.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocyte derived endothelial progenitor cells, donor2 | 11310-117C5 |
134.57 | 70.13 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocyte derived endothelial progenitor cells, donor3 | 11386-118B9 |
133.80 | 56.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - mock treated, donor1 | 11863-125A9 |
64.90 | 3.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - mock treated, donor2 | 11873-125C1 |
62.76 | 2.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - mock treated, donor3 | 11883-125D2 |
43.11 | 4.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with B-glucan, donor1 | 11869-125B6 |
49.21 | 3.52 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with B-glucan, donor2 | 11879-125C7 |
53.55 | 4.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with B-glucan, donor3 | 11889-125D8 |
53.06 | 3.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with BCG, donor1 | 11860-125A6 |
53.65 | 4.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with BCG, donor2 | 11870-125B7 |
62.67 | 7.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with BCG, donor3 | 11880-125C8 |
79.00 | 7.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Candida, donor1 | 11868-125B5 |
63.68 | 3.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Candida, donor2 | 11878-125C6 |
86.60 | 4.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Candida, donor3 | 11888-125D7 |
72.11 | 3.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Cryptococcus, donor1 | 11867-125B4 |
63.66 | 4.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Cryptococcus, donor2 | 11877-125C5 |
67.65 | 3.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Cryptococcus, donor3 | 11887-125D6 |
58.30 | 4.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Group A streptococci, donor1 | 11864-125B1 |
72.52 | 4.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Group A streptococci, donor2 | 11874-125C2 |
69.90 | 7.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Group A streptococci, donor3 | 11884-125D3 |
45.39 | 6.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with IFN + N-hexane, donor1 | 11861-125A7 |
54.87 | 6.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with IFN + N-hexane, donor2 | 11871-125B8 |
74.15 | 7.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with IFN + N-hexane, donor3 | 11881-125C9 |
50.50 | 7.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Salmonella, donor1 | 11866-125B3 |
66.14 | 3.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Salmonella, donor2 | 11876-125C4 |
58.83 | 3.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Salmonella, donor3 | 11886-125D5 |
32.03 | 2.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1 | 11862-125A8 |
53.01 | 6.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2 | 11872-125B9 |
72.85 | 6.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3 | 11882-125D1 |
80.83 | 6.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with lipopolysaccharide, donor1 | 11865-125B2 |
73.71 | 12.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with lipopolysaccharide, donor2 | 11875-125C3 |
88.08 | 5.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+ monocytes - treated with lipopolysaccharide, donor3 | 11885-125D4 |
62.17 | 5.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+CD16+ Monocytes, donor1 | 11789-124B7 |
70.62 | 22.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+CD16+ Monocytes, donor2 | 11801-124D1 |
68.37 | 24.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+CD16+ Monocytes, donor3 | 11912-125G4 |
92.93 | 28.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+CD16- Monocytes, donor1 | 11788-124B6 |
112.90 | 29.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+CD16- Monocytes, donor2 | 11799-124C8 |
109.68 | 30.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14+CD16- Monocytes, donor3 | 11910-125G2 |
105.69 | 26.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14-CD16+ Monocytes, donor1 | 11790-124B8 |
42.87 | 14.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14-CD16+ Monocytes, donor2 | 11800-124C9 |
45.45 | 16.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD14-CD16+ Monocytes, donor3 | 11911-125G3 |
60.22 | 18.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090309, donation1 | 12189-129B2 |
304.85 | 87.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090309, donation2 | 12194-129B7 |
284.75 | 74.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090309, donation3 | 12199-129C3 |
325.18 | 83.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090325, donation1 | 12151-128F9 |
302.23 | 94.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090325, donation2 | 12174-128I5 |
293.77 | 89.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090612, donation1 | 12204-129C8 |
240.06 | 87.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090612, donation2 | 12209-129D4 |
269.03 | 82.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells (pluriselect), donor090612, donation3 | 12214-129D9 |
321.66 | 85.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells, donor1 | 11544-120B5 |
92.05 | 13.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells, donor2 | 11624-122B4 |
122.60 | 10.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD19+ B Cells, donor3 | 11705-123B4 |
108.54 | 14.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep1 | 11931-125I5 |
364.46 | 157.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep2 | 11932-125I6 |
299.62 | 121.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD34+ Progenitors, donor1 | 11545-120B6 |
513.07 | 104.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD34+ Progenitors, donor2 | 11625-122B5 |
686.53 | 94.95 | 1.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1 | 12225-129F2 |
859.73 | 312.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2 | 12225-129F2 |
1020.31 | 379.04 | 0.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+ T Cells, donor1 | 11225-116C1 |
707.69 | 119.26 | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 |
CD4+ T Cells, donor2 | 11306-117C1 |
718.91 | 75.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+ T Cells, donor3 | 11382-118B5 |
647.81 | 109.80 | 0.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1 | 11793-124C2 |
778.47 | 442.58 | 0.51 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2 | 11915-125G7 |
856.61 | 465.59 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 11919-125H2 |
806.61 | 433.49 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1 | 11780-124A7 |
1171.00 | 457.97 | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2 | 11796-124C5 |
1636.41 | 569.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3 | 11907-125F8 |
1229.49 | 491.14 | 3.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1 | 11794-124C3 |
580.52 | 365.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2 | 11916-125G8 |
488.22 | 203.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3 | 11920-125H3 |
402.69 | 179.91 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1 | 11782-124A9 |
782.28 | 285.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2 | 11797-124C6 |
905.96 | 369.30 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3 | 11908-125F9 |
957.40 | 328.23 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1 | 11791-124B9 |
1037.66 | 743.35 | 2.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2 | 11913-125G5 |
677.74 | 376.48 | 1.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3 | 11917-125G9 |
766.82 | 458.42 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1 | 11784-124B2 |
1077.40 | 503.62 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2 | 11795-124C4 |
1290.57 | 529.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3 | 11906-125F7 |
1235.53 | 484.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1 | 11792-124C1 |
839.62 | 530.51 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2 | 11914-125G6 |
582.27 | 360.02 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3 | 11918-125H1 |
468.01 | 259.96 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA- memory conventional T cells, donor1 | 11786-124B4 |
918.68 | 377.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA- memory conventional T cells, donor2 | 11798-124C7 |
1097.43 | 452.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD4+CD25-CD45RA- memory conventional T cells, donor3 | 11909-125G1 |
1086.49 | 468.50 | 0.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090309, donation1 | 12186-129A8 |
1308.43 | 593.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090309, donation2 | 12191-129B4 |
1188.14 | 487.44 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090309, donation3 | 12196-129B9 |
1247.87 | 565.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090325, donation1 | 12148-128F6 |
1241.19 | 591.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090325, donation2 | 12171-128I2 |
1378.36 | 663.78 | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090612, donation1 | 12201-129C5 |
1298.23 | 577.50 | 1.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090612, donation2 | 12206-129D1 |
911.41 | 439.77 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells (pluriselect), donor090612, donation3 | 12211-129D6 |
999.96 | 419.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells, donor1 | 11226-116C2 |
385.34 | 66.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells, donor2 | 11307-117C2 |
269.56 | 28.16 | 0.38 | 0.00 | 0.38 | 0.00 | 0.00 | 0.00 |
CD8+ T Cells, donor3 | 11383-118B6 |
531.24 | 62.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 00hr, biol_rep1 | 13553-145I7 |
192.92 | 96.12 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 00hr, biol_rep2 | 13554-145I8 |
177.10 | 92.98 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 00hr, biol_rep3 | 13555-145I9 |
216.14 | 105.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 06hr, biol_rep1 | 13556-146A1 |
314.02 | 134.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 06hr, biol_rep2 | 13557-146A2 |
176.39 | 68.16 | 0.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 06hr, biol_rep3 | 13558-146A3 |
201.92 | 90.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 12hr, biol_rep1 | 13559-146A4 |
209.46 | 135.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 12hr, biol_rep2 | 13560-146A5 |
184.51 | 133.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 12hr, biol_rep3 | 13561-146A6 |
180.58 | 125.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 24hr, biol_rep1 | 13562-146A7 |
189.88 | 174.79 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 24hr, biol_rep2 | 13563-146A8 |
196.38 | 157.16 | 0.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 24hr, biol_rep3 | 13564-146A9 |
243.79 | 155.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 48hr, biol_rep1 | 13565-146B1 |
119.51 | 45.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 48hr, biol_rep2 | 13566-146B2 |
157.12 | 55.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest infection, 48hr, biol_rep3 | 13567-146B3 |
96.22 | 41.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep1 | 13568-146B4 |
211.77 | 85.72 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 13569-146B5 |
194.79 | 83.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep3 | 13570-146B6 |
201.28 | 82.49 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep1 | 13571-146B7 |
264.30 | 145.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep2 | 13572-146B8 |
216.83 | 128.56 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep3 | 13573-146B9 |
207.74 | 100.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep1 | 13574-146C1 |
216.09 | 136.92 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep2 | 13575-146C2 |
187.59 | 124.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep3 | 13576-146C3 |
174.73 | 147.50 | 0.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep1 | 13577-146C4 |
102.78 | 52.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep2 | 13578-146C5 |
148.28 | 37.77 | 0.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep3 | 13579-146C6 |
130.23 | 43.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cardiac Myocyte, donor1 | 11525-119I4 |
175.46 | 118.80 | 1.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cardiac Myocyte, donor2 | 11605-120I3 |
312.26 | 201.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cardiac Myocyte, donor3 | 11686-122I3 |
312.01 | 158.06 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Chondrocyte - de diff, donor1 | 11261-116G1 |
229.15 | 150.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Chondrocyte - de diff, donor2 | 11338-117F6 |
164.54 | 80.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Chondrocyte - de diff, donor3 | 11410-118E6 |
235.98 | 120.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Chondrocyte - re diff, donor2 | 11339-117F7 |
218.44 | 139.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Chondrocyte - re diff, donor3 | 11411-118E7 |
113.64 | 31.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ciliary Epithelial Cells, donor1 | 11242-116D9 |
569.32 | 360.69 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ciliary Epithelial Cells, donor2 | 11323-117D9 |
424.32 | 225.10 | 0.00 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 |
Ciliary Epithelial Cells, donor3 | 11399-118D4 |
435.32 | 217.79 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Clontech Human Universal Reference Total RNA, pool1 | 10000-101A1 |
218.80 | 201.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corneal Epithelial Cells, donor1 | 11526-119I5 |
35.79 | 11.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corneal Epithelial Cells, donor2 | 11606-120I4 |
54.60 | 40.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corneal Epithelial Cells, donor3 | 11687-122I4 |
59.05 | 32.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dendritic Cells - monocyte immature derived, donor1, rep2 | 11227-116C3 |
85.52 | 44.25 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1 | 11227-116C3 |
99.67 | 52.04 | 0.00 | 0.32 | 0.32 | 0.00 | 0.00 | 0.00 |
Dendritic Cells - monocyte immature derived, donor2 | 11308-117C3 |
131.13 | 72.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dendritic Cells - monocyte immature derived, donor3 | 11384-118B7 |
124.62 | 49.14 | 0.11 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Dendritic Cells - plasmacytoid, donor1 | 11228-116C4 |
335.83 | 62.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dendritic Cells - plasmacytoid, donor2 | 11309-117C4 |
461.58 | 99.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dendritic Cells - plasmacytoid, donor3 | 11385-118B8 |
433.61 | 79.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Aortic, donor0 | 11207-116A1 |
155.43 | 89.55 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Aortic, donor1 | 11263-116G3 |
108.55 | 69.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Aortic, donor2 | 11340-117F8 |
162.33 | 94.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Aortic, donor3 | 11412-118E8 |
176.93 | 84.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Artery, donor1 | 11264-116G4 |
137.58 | 85.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Artery, donor2 | 11341-117F9 |
298.57 | 141.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Artery, donor3 | 11413-118E9 |
154.62 | 81.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Lymphatic, donor1 | 11236-116D3 |
236.50 | 103.29 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Lymphatic, donor2 | 11317-117D3 |
215.73 | 113.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Lymphatic, donor3 | 11393-118C7 |
153.36 | 73.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Microvascular, donor1 | 11265-116G5 |
114.99 | 41.30 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Microvascular, donor2 | 11342-117G1 |
62.48 | 36.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Microvascular, donor3 | 11414-118F1 |
66.07 | 9.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Thoracic, donor1 | 11266-116G6 |
255.28 | 170.45 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Thoracic, donor2 | 11343-117G2 |
133.13 | 66.56 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Umbilical vein, donor1 | 11243-116E1 |
555.88 | 374.73 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Umbilical vein, donor2 | 11324-117E1 |
281.79 | 153.39 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Umbilical vein, donor3 | 11400-118D5 |
300.80 | 151.07 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Vein, donor1 | 11267-116G7 |
122.85 | 86.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Vein, donor2 | 11344-117G3 |
117.35 | 65.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Endothelial Cells - Vein, donor3 | 11416-118F3 |
231.27 | 105.19 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Eosinophils, donor1 | 12244-129H3 |
457.41 | 60.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Eosinophils, donor2 | 12245-129H4 |
44.56 | 1.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Eosinophils, donor3 | 12246-129H5 |
60.64 | 10.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Esophageal Epithelial Cells, donor1 | 11507-119G4 |
26.63 | 18.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Esophageal Epithelial Cells, donor2 | 11587-120G3 |
8.32 | 6.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Esophageal Epithelial Cells, donor3 | 11668-122G3 |
211.49 | 162.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ewing's sarcoma cell line:Hs 863.T | 10705-109H3 |
134.24 | 57.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction) | 14331-155F2 |
86.50 | 63.72 | 0.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction) | 14310-155C8 |
121.45 | 78.54 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Aortic Adventitial, donor1 | 11245-116E3 |
266.45 | 203.87 | 0.12 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction) | 14332-155F3 |
256.57 | 226.95 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Aortic Adventitial, donor2 | 11326-117E3 |
215.05 | 101.88 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction) | 14311-155C9 |
153.61 | 172.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Aortic Adventitial, donor3 | 11401-118D6 |
215.27 | 121.59 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Cardiac, donor1 | 11268-116G8 |
229.08 | 144.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Cardiac, donor2 | 11345-117G4 |
130.37 | 69.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Cardiac, donor3 | 11417-118F4 |
148.88 | 74.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Cardiac, donor4 | 11452-119A3 |
316.14 | 159.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Cardiac, donor5 | 11456-119A7 |
326.40 | 131.22 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Cardiac, donor6 | 11460-119B2 |
320.62 | 199.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Choroid Plexus, donor1 | 11492-119E7 |
115.63 | 55.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Choroid Plexus, donor2 | 11572-120E6 |
219.60 | 145.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Choroid Plexus, donor3 | 11653-122E6 |
392.56 | 294.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Conjunctival, donor1 | 11531-120A1 |
68.04 | 25.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Conjunctival, donor3 | 11692-122I9 |
505.25 | 138.40 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Dermal, donor1 | 11269-116G9 |
441.86 | 206.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Dermal, donor2 | 11346-117G5 |
175.46 | 133.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Dermal, donor3 | 11418-118F5 |
445.59 | 144.94 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Dermal, donor4 | 11450-119A1 |
448.68 | 218.86 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Dermal, donor5 | 11454-119A5 |
447.12 | 273.72 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Dermal, donor6 | 11458-119A9 |
538.43 | 353.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor1 | 11237-116D4 |
374.40 | 185.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor10 (periodontitis) | 11928-125I2 |
173.71 | 99.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor2 | 11318-117D4 |
476.53 | 255.79 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor3 | 11394-118C8 |
306.59 | 75.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor4 (GFH2) | 11222-116B7 |
146.48 | 66.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor5 (GFH3) | 11303-117B7 |
137.79 | 63.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor6 (aggressive periodontitis) | 11921-125H4 |
245.38 | 142.80 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor6 (control) | 11922-125H5 |
218.80 | 144.02 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor7 (aggressive periodontitis) | 11923-125H6 |
41.29 | 25.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor7 (control) | 11924-125H7 |
214.10 | 129.13 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor8 (chronic periodontitis) | 11925-125H8 |
226.07 | 165.67 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor8 (control) | 11926-125H9 |
228.82 | 148.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Gingival, donor9 (control) | 11927-125I1 |
139.26 | 47.25 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Lung, donor1 | 11270-116H1 |
118.26 | 51.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Lung, donor2 | 11347-117G6 |
370.05 | 176.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Lung, donor3 | 11419-118F6 |
452.67 | 169.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Lymphatic, donor1 | 11506-119G3 |
34.99 | 24.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Lymphatic, donor2 | 11586-120G2 |
43.36 | 15.38 | 1.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Lymphatic, donor3 | 11667-122G2 |
7.28 | 3.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Mammary, donor1 | 11540-120B1 |
68.20 | 33.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Mammary, donor2 | 11620-122A9 |
15.98 | 15.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Mammary, donor3 | 11701-123A9 |
65.52 | 17.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Periodontal Ligament, donor1 | 11238-116D5 |
438.77 | 385.62 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Periodontal Ligament, donor2 | 11319-117D5 |
372.83 | 231.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Periodontal Ligament, donor3 | 11395-118C9 |
250.91 | 134.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Periodontal Ligament, donor4 (PL29) | 11223-116B8 |
165.62 | 94.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Periodontal Ligament, donor5 (PL30) | 11304-117B8 |
220.04 | 105.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Periodontal Ligament, donor6 (PLH3) | 11380-118B3 |
160.04 | 62.74 | 0.12 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 |
Fibroblast - Pulmonary Artery, donor1 | 11250-116E8 |
340.88 | 280.42 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Villous Mesenchymal, donor1 | 11535-120A5 |
48.97 | 27.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Villous Mesenchymal, donor2 | 11615-122A4 |
52.12 | 36.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - Villous Mesenchymal, donor3 | 11696-123A4 |
285.45 | 155.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 14329-155E9 |
229.60 | 183.37 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin dystrophia myotonica, donor1 | 11556-120C8 |
207.99 | 70.87 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin dystrophia myotonica, donor2 | 11557-120C9 |
271.78 | 132.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction) | 14308-155C6 |
202.17 | 161.26 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin dystrophia myotonica, donor3 | 11560-120D3 |
293.09 | 136.45 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin normal, donor1 (nuclear fraction) | 14323-155E3 |
188.54 | 165.76 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin normal, donor1 | 11553-120C5 |
195.91 | 100.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin normal, donor2 (nuclear fraction) | 14302-155B9 |
230.38 | 168.23 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin normal, donor2 | 11561-120D4 |
239.80 | 117.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction) | 14326-155E6 |
273.83 | 238.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin spinal muscular atrophy, donor1 | 11555-120C7 |
232.38 | 102.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin spinal muscular atrophy, donor2 | 11558-120D1 |
368.23 | 131.29 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 14305-155C3 |
125.13 | 111.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin spinal muscular atrophy, donor3 | 11559-120D2 |
248.30 | 137.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin walker warburg, donor1 | 11554-120C6 |
273.09 | 196.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin, normal donor1 (cytoplasmic fraction) | 14322-155E2 |
207.79 | 77.47 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fibroblast - skin, normal donor2 (cytoplasmic fraction) | 14301-155B8 |
3080.21 | 1728.46 | 22.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fingernail (including nail plate, eponychium and hyponychium), donor2 | 10301-104H4 |
27.02 | 11.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gingival epithelial cells, donor1 (GEA11) | 11221-116B6 |
177.34 | 118.06 | 0.17 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 |
Gingival epithelial cells, donor2 (GEA14) | 11302-117B6 |
224.07 | 138.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gingival epithelial cells, donor3 (GEA15) | 11379-118B2 |
179.37 | 117.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1 | 13523-145F4 |
566.51 | 503.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2 | 13524-145F5 |
769.51 | 805.88 | 1.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3 | 13525-145F6 |
1345.30 | 1033.80 | 1.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1 | 13526-145F7 |
500.22 | 159.94 | 0.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2 | 13527-145F8 |
409.16 | 224.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3 | 13528-145F9 |
763.59 | 526.63 | 0.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1 | 13529-145G1 |
503.82 | 173.14 | 1.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2 | 13530-145G2 |
306.58 | 162.75 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3 | 13531-145G3 |
1262.11 | 821.65 | 1.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0) | 12627-134E8 |
831.12 | 445.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0) | 12725-135G7 |
436.54 | 237.54 | 1.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0) | 12823-136I6 |
611.39 | 379.57 | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1) | 12628-134E9 |
425.95 | 216.94 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1) | 12726-135G8 |
574.47 | 259.83 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1) | 12824-136I7 |
550.14 | 342.36 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3) | 12629-134F1 |
396.57 | 269.48 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3) | 12727-135G9 |
449.68 | 204.79 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3) | 12825-136I8 |
349.50 | 176.83 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6) | 12630-134F2 |
478.97 | 295.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6) | 12728-135H1 |
485.78 | 288.67 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6) | 12826-136I9 |
352.11 | 216.49 | 0.00 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9) | 12631-134F3 |
451.05 | 293.58 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9) | 12729-135H2 |
550.32 | 418.17 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9) | 12827-137A1 |
489.65 | 491.24 | 0.27 | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
434.64 | 321.64 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
440.43 | 339.50 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12) | 12730-135H3 |
526.82 | 315.81 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
514.15 | 467.90 | 0.08 | 0.08 | 0.00 | 0.08 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
539.85 | 491.46 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15) | 12633-134F5 |
562.39 | 345.77 | 0.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15) | 12731-135H4 |
558.60 | 298.38 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15) | 12829-137A3 |
456.27 | 327.69 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18) | 12634-134F6 |
410.22 | 237.40 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18) | 12732-135H5 |
634.64 | 378.69 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18) | 12830-137A4 |
450.46 | 317.70 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21) | 12635-134F7 |
497.75 | 263.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21) | 12733-135H6 |
425.64 | 251.19 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21) | 12831-137A5 |
400.19 | 277.92 | 0.47 | 0.00 | 0.32 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24) | 12636-134F8 |
415.38 | 304.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24) | 12734-135H7 |
401.95 | 274.31 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24) | 12832-137A6 |
431.65 | 289.59 | 0.44 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27) | 12637-134F9 |
350.69 | 283.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27) | 12735-135H8 |
288.22 | 227.12 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27) | 12833-137A7 |
469.56 | 405.65 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30) | 12638-134G1 |
306.32 | 306.32 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30) | 12736-135H9 |
350.01 | 260.50 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30) | 12834-137A8 |
426.67 | 327.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34) | 12639-134G2 |
334.04 | 272.47 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34) | 12737-135I1 |
352.65 | 265.37 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34) | 12835-137A9 |
252.90 | 187.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41) | 12640-134G3 |
260.79 | 239.82 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41) | 12738-135I2 |
272.57 | 192.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41) | 12836-137B1 |
196.47 | 159.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryonic Stem cells, biol_rep1 (H9ES-1) | 12626-134E7 |
1136.83 | 636.59 | 1.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2) | 12724-135G6 |
662.99 | 352.06 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3) | 12822-136I5 |
1012.68 | 589.61 | 1.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1) | 13364-143F7 |
766.68 | 772.62 | 0.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2) | 13365-143F8 |
762.33 | 806.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3) | 13366-143F9 |
867.99 | 669.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1 | 13328-143B7 |
786.99 | 593.95 | 4.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2 | 13340-143D1 |
739.19 | 755.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3 | 13352-143E4 |
675.48 | 890.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1 | 13329-143B8 |
606.85 | 415.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2 | 13341-143D2 |
726.47 | 675.04 | 1.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3 | 13353-143E5 |
842.55 | 804.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1 | 13330-143B9 |
483.18 | 436.53 | 3.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2 | 13342-143D3 |
625.29 | 582.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3 | 13354-143E6 |
601.72 | 548.77 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1 | 13331-143C1 |
582.15 | 411.03 | 3.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2 | 13343-143D4 |
689.90 | 561.08 | 0.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3 | 13355-143E7 |
672.53 | 611.39 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1 | 13332-143C2 |
1194.42 | 797.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2 | 13344-143D5 |
891.12 | 608.78 | 1.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3 | 13356-143E8 |
526.85 | 371.75 | 0.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1 | 13333-143C3 |
718.32 | 716.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2 | 13345-143D6 |
636.64 | 683.86 | 0.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3 | 13357-143E9 |
582.46 | 564.97 | 0.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1 | 13334-143C4 |
669.10 | 416.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2 | 13346-143D7 |
563.16 | 503.58 | 1.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3 | 13358-143F1 |
510.80 | 433.87 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1 | 13335-143C5 |
768.50 | 492.27 | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2 | 13347-143D8 |
908.08 | 446.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3 | 13359-143F2 |
640.52 | 414.57 | 0.34 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1 | 13336-143C6 |
683.32 | 330.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2 | 13348-143D9 |
834.70 | 339.26 | 0.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3 | 13360-143F3 |
678.93 | 337.96 | 1.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1 | 13337-143C7 |
839.82 | 406.94 | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2 | 13349-143E1 |
738.25 | 415.59 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3 | 13361-143F4 |
900.87 | 487.44 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1 | 13338-143C8 |
895.95 | 435.58 | 2.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2 | 13350-143E2 |
820.91 | 395.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3 | 13362-143F5 |
809.30 | 301.07 | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1 | 13339-143C9 |
713.76 | 266.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2 | 13351-143E3 |
556.92 | 362.33 | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3 | 13363-143F6 |
579.87 | 474.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor1 | 11271-116H2 |
85.60 | 51.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor2 | 11348-117G7 |
186.29 | 91.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor3 | 11420-118F7 |
100.08 | 60.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hair Follicle Outer Root Sheath Cells, donor1 | 11504-119G1 |
252.46 | 78.02 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hair Follicle Outer Root Sheath Cells, donor2 | 11584-120F9 |
252.32 | 86.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hep-2 cells mock treated, biol_rep1 | 11898-125E8 |
682.79 | 494.57 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hep-2 cells mock treated, biol_rep2 | 11899-125E9 |
656.47 | 475.18 | 0.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hep-2 cells mock treated, biol_rep3 | 11900-125F1 |
684.33 | 464.79 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1 | 11890-125D9 |
668.42 | 485.66 | 0.55 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2 | 11891-125E1 |
654.19 | 448.52 | 0.21 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3 | 11892-125E2 |
660.06 | 446.50 | 0.22 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1 | 11894-125E4 |
752.83 | 499.15 | 0.62 | 0.25 | 0.12 | 0.00 | 0.00 | 0.00 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2 | 11895-125E5 |
637.99 | 484.63 | 0.69 | 0.17 | 0.00 | 0.17 | 0.00 | 0.00 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3 | 11896-125E6 |
660.61 | 472.23 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hepatic Sinusoidal Endothelial Cells, donor1 | 11521-119H9 |
62.68 | 22.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hepatic Sinusoidal Endothelial Cells, donor2 | 11601-120H8 |
11.25 | 6.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hepatic Sinusoidal Endothelial Cells, donor3 | 11682-122H8 |
341.05 | 388.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor1 | 11524-119I3 |
44.09 | 21.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor2 | 11604-120I2 |
28.33 | 13.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor3 | 11685-122I2 |
311.74 | 232.01 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Hepatocyte, donor1 | 11523-119I2 |
1.21 | 3.63 | 0.00 | 0.00 | 0.00 | 0.00 | 2.42 | 1.21 |
Hepatocyte, donor2 | 11603-120I1 |
7.54 | 5.39 | 0.00 | 0.00 | 0.00 | 0.00 | 1.08 | 0.00 |
Hepatocyte, donor3 | 11684-122I1 |
43.56 | 26.38 | 0.61 | 0.00 | 0.00 | 0.00 | 2.45 | 2.45 |
Hodgkin's lymphoma cell line:HD-Mar2 | 10435-106E3 |
687.93 | 402.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intestinal epithelial cells (polarized), donor1 | 11246-116E4 |
483.45 | 591.99 | 0.17 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 |
Iris Pigment Epithelial Cells, donor1 | 11530-119I9 |
364.42 | 253.83 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1 | 13079-140B1 |
47.76 | 31.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 13145-140I4 |
113.48 | 20.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3 | 13211-141G7 |
189.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1 | 13080-140B2 |
67.83 | 47.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2 | 13146-140I5 |
95.10 | 57.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3 | 13212-141G8 |
237.37 | 237.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1 | 13081-140B3 |
53.82 | 38.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2 | 13147-140I6 |
95.99 | 59.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3 | 13213-141G9 |
112.08 | 74.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1 | 13082-140B4 |
113.38 | 55.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2 | 13148-140I7 |
98.03 | 68.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3 | 13214-141H1 |
76.76 | 50.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1 | 13083-140B5 |
130.82 | 126.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2 | 13149-140I8 |
94.29 | 68.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3 | 13215-141H2 |
142.98 | 96.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1 | 13084-140B6 |
89.70 | 64.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2 | 13150-140I9 |
58.54 | 43.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3 | 13216-141H3 |
86.57 | 59.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1 | 13085-140B7 |
85.33 | 33.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2 | 13151-141A1 |
35.84 | 47.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3 | 13217-141H4 |
120.60 | 70.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1 | 13086-140B8 |
79.34 | 53.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2 | 13152-141A2 |
57.49 | 57.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3 | 13218-141H5 |
110.10 | 67.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1 | 13087-140B9 |
87.71 | 53.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2 | 13153-141A3 |
30.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3 | 13219-141H6 |
142.56 | 79.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1 | 13088-140C1 |
111.56 | 72.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2 | 13154-141A4 |
73.71 | 73.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3 | 13220-141H7 |
103.31 | 60.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1 | 13089-140C2 |
99.10 | 67.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2 | 13155-141A5 |
0.00 | 16.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 13221-141H8 |
95.01 | 51.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1 | 13090-140C3 |
74.73 | 60.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2 | 13156-141A6 |
63.22 | 63.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3 | 13222-141H9 |
92.11 | 67.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1 | 13091-140C4 |
76.32 | 46.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2 | 13157-141A7 |
41.70 | 62.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3 | 13223-141I1 |
152.79 | 100.01 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1 | 13092-140C5 |
93.07 | 49.17 | 1.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 13158-141A8 |
88.01 | 44.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3 | 13224-141I2 |
71.62 | 55.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1 | 13093-140C6 |
46.47 | 46.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2 | 13159-141A9 |
110.23 | 64.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3 | 13225-141I3 |
72.37 | 40.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep1 | 13094-140C7 |
49.50 | 40.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 13160-141B1 |
45.30 | 52.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep3 | 13226-141I4 |
84.28 | 38.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep1 | 13095-140C8 |
73.43 | 37.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep2 | 13161-141B2 |
37.04 | 42.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep3 | 13227-141I5 |
67.19 | 47.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep1 | 13096-140C9 |
72.61 | 36.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep2 | 13162-141B3 |
99.34 | 37.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep3 | 13228-141I6 |
58.16 | 17.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Keratinocyte - epidermal, donor1 | 11272-116H3 |
199.59 | 129.50 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Keratinocyte - epidermal, donor2 | 11349-117G8 |
105.41 | 38.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Keratinocyte - epidermal, donor3 | 11421-118F8 |
344.36 | 158.26 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Keratinocyte - oral, donor1 | 11251-116E9 |
662.71 | 300.03 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Keratocytes, donor1 | 11527-119I6 |
59.14 | 33.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Keratocytes, donor2 | 11607-120I5 |
36.33 | 15.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Keratocytes, donor3 | 11688-122I5 |
255.49 | 124.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Krukenberg tumor cell line:HSKTC | 10687-109F3 |
26.37 | 10.99 | 2.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lens Epithelial Cells, donor1 | 11529-119I8 |
289.10 | 215.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lens Epithelial Cells, donor2 | 11609-120I7 |
459.02 | 230.66 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lens Epithelial Cells, donor3 | 11690-122I7 |
289.91 | 204.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1) | 12260-130A1 |
145.26 | 57.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1) | 12382-131E6 |
121.12 | 53.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ) | 12504-133A2 |
148.28 | 65.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2) | 12261-130A2 |
128.51 | 51.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2) | 12383-131E7 |
93.60 | 45.07 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2) | 12505-133A3 |
98.76 | 44.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3) | 12262-130A3 |
122.30 | 50.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3) | 12384-131E8 |
73.32 | 31.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3) | 12506-133A4 |
107.67 | 41.66 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4) | 12263-130A4 |
136.85 | 52.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4) | 12385-131E9 |
132.03 | 53.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4) | 12507-133A5 |
56.84 | 24.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5) | 12264-130A5 |
130.66 | 56.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5) | 12386-131F1 |
117.59 | 46.27 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5) | 12508-133A6 |
106.17 | 42.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6) | 12265-130A6 |
137.66 | 51.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6) | 12387-131F2 |
69.52 | 32.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6) | 12509-133A7 |
87.10 | 35.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7) | 12266-130A7 |
113.21 | 45.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7) | 12388-131F3 |
72.05 | 33.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7) | 12510-133A8 |
58.75 | 28.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8) | 12267-130A8 |
140.15 | 58.20 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8) | 12389-131F4 |
144.88 | 59.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8) | 12511-133A9 |
112.63 | 48.74 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9) | 12268-130A9 |
116.64 | 60.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9) | 12390-131F5 |
137.99 | 58.63 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9) | 12512-133B1 |
93.98 | 39.40 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10) | 12269-130B1 |
130.01 | 50.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10) | 12391-131F6 |
129.07 | 52.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10) | 12513-133B2 |
83.66 | 33.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11) | 12270-130B2 |
113.39 | 54.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11) | 12392-131F7 |
127.35 | 41.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11) | 12514-133B3 |
83.87 | 30.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 12271-130B3 |
138.83 | 65.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12) | 12393-131F8 |
130.21 | 51.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12) | 12515-133B4 |
90.20 | 33.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13) | 12272-130B4 |
128.01 | 44.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13) | 12394-131F9 |
142.73 | 50.82 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13) | 12516-133B5 |
149.62 | 54.03 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14) | 12273-130B5 |
126.22 | 43.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14) | 12395-131G1 |
100.83 | 40.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14) | 12517-133B6 |
54.31 | 20.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15) | 12274-130B6 |
126.77 | 53.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15) | 12396-131G2 |
108.46 | 43.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15) | 12518-133B7 |
54.62 | 28.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16) | 12275-130B7 |
119.42 | 43.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16) | 12397-131G3 |
65.31 | 23.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16) | 12519-133B8 |
93.09 | 30.73 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1 | 13031-139E7 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2 | 13097-140D1 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3 | 13163-141B4 |
0.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1 | 13032-139E8 |
0.42 | 1.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2 | 13098-140D2 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3 | 13164-141B5 |
0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1 | 13033-139E9 |
0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2 | 13099-140D3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3 | 13165-141B6 |
0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1 | 13034-139F1 |
0.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2 | 13100-140D4 |
0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3 | 13166-141B7 |
0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1 | 13035-139F2 |
0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2 | 13101-140D5 |
0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 13167-141B8 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1 | 13036-139F3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2 | 13102-140D6 |
0.27 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3 | 13168-141B9 |
0.38 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1 | 13037-139F4 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2 | 13103-140D7 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3 | 13169-141C1 |
0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1 | 13038-139F5 |
0.56 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2 | 13104-140D8 |
1.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3 | 13170-141C2 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1 | 13039-139F6 |
0.90 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2 | 13105-140D9 |
1.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3 | 13171-141C3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1 | 13040-139F7 |
0.00 | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2 | 13106-140E1 |
1.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3 | 13172-141C4 |
0.00 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1 | 13041-139F8 |
0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2 | 13107-140E2 |
0.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3 | 13173-141C5 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1 | 13042-139F9 |
0.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2 | 13108-140E3 |
0.00 | 0.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3 | 13174-141C6 |
0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1 | 13043-139G1 |
0.43 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2 | 13109-140E4 |
0.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3 | 13175-141C7 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1 | 13044-139G2 |
0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2 | 13110-140E5 |
0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3 | 13176-141C8 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1 | 13045-139G3 |
0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2 | 13111-140E6 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3 | 13177-141C9 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1 | 13046-139G4 |
0.00 | 1.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2 | 13112-140E7 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3 | 13178-141D1 |
0.40 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1 | 13048-139G6 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 13114-140E9 |
1.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3 | 13180-141D3 |
0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1 | 13049-139G7 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 13115-140F1 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3 | 13181-141D4 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1 | 13050-139G8 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 13116-140F2 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3 | 13182-141D5 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1 | 13051-139G9 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 13117-140F3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3 | 13183-141D6 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1 | 13052-139H1 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 13118-140F4 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3 | 13184-141D7 |
1.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1 | 13053-139H2 |
0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 13119-140F5 |
0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3 | 13185-141D8 |
0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1 | 13054-139H3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 13120-140F6 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3 | 13186-141D9 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1 | 13055-139H4 |
0.00 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 13121-140F7 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3 | 13187-141E1 |
0.63 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1 | 13056-139H5 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 13122-140F8 |
1.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3 | 13188-141E2 |
1.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1 | 13057-139H6 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 13123-140F9 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3 | 13189-141E3 |
0.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1 | 13058-139H7 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 13124-140G1 |
0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3 | 13190-141E4 |
0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1 | 13059-139H8 |
0.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 13125-140G2 |
0.00 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3 | 13191-141E5 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1 | 13060-139H9 |
0.00 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 13126-140G3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3 | 13192-141E6 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1 | 13061-139I1 |
0.00 | 0.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 13127-140G4 |
0.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3 | 13193-141E7 |
0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1 | 13062-139I2 |
0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 13128-140G5 |
0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3 | 13194-141E8 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Macrophage - monocyte derived, donor1 | 11232-116C8 |
99.83 | 55.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Macrophage - monocyte derived, donor2 | 11313-117C8 |
108.64 | 62.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Macrophage - monocyte derived, donor3 | 11389-118C3 |
131.08 | 59.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mallassez-derived cells, donor1 (MZH3) | 12142-128E9 |
317.02 | 224.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mallassez-derived cells, donor2 | 11929-125I3 |
173.98 | 85.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mallassez-derived cells, donor3 | 11930-125I4 |
403.48 | 251.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mammary Epithelial Cell, donor1 | 11273-116H4 |
450.89 | 95.96 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mammary Epithelial Cell, donor2 | 11350-117G9 |
476.02 | 199.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mammary Epithelial Cell, donor3 | 11422-118F9 |
147.91 | 58.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell - stimulated, donor1 | 11487-119E2 |
467.78 | 351.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, donor1 | 11563-120D6 |
414.61 | 279.54 | 0.32 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, donor2 | 11565-120D8 |
120.65 | 34.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, donor3 | 11566-120D9 |
162.54 | 46.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, donor4 | 11567-120E1 |
95.91 | 25.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, expanded and stimulated, donor5 | 11940-126A5 |
240.19 | 157.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, expanded and stimulated, donor8 | 11942-126A7 |
291.84 | 181.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, expanded, donor5 | 11939-126A4 |
321.45 | 230.02 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mast cell, expanded, donor8 | 11941-126A6 |
271.47 | 205.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Melanocyte - dark, donor1 | 11502-119F8 |
186.16 | 56.81 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Melanocyte - dark, donor2 | 11582-120F7 |
339.16 | 206.96 | 1.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Melanocyte - dark, donor3 | 11663-122F7 |
306.13 | 365.46 | 0.14 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 |
Melanocyte - light, donor1 | 11274-116H5 |
82.04 | 72.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Melanocyte - light, donor2 | 11351-117H1 |
78.48 | 88.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Melanocyte - light, donor3 | 11423-118G1 |
78.05 | 46.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Melanocyte, donor1 (MC+1) | 12641-134G4 |
343.30 | 299.15 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Melanocyte, donor2 (MC+2) | 12739-135I3 |
324.08 | 355.00 | 0.81 | 0.00 | 0.27 | 0.00 | 0.00 | 0.00 |
Melanocyte, donor3 (MC+3) | 12837-137B2 |
265.98 | 337.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Meningeal Cells, donor1 | 11493-119E8 |
141.30 | 87.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Meningeal Cells, donor2 | 11573-120E7 |
197.63 | 82.75 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Meningeal Cells, donor3 | 11654-122E7 |
460.24 | 404.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - Vertebral, donor1 | 11219-116B4 |
473.36 | 316.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1 | 11548-120B9 |
218.98 | 136.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - adipose, donor1 | 11537-120A7 |
31.54 | 18.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - adipose, donor2 | 11617-122A6 |
40.55 | 34.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - adipose, donor3 | 11698-123A6 |
344.45 | 205.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - amniotic membrane, donor1 | 11547-120B8 |
294.15 | 178.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - amniotic membrane, donor2 | 11627-122B7 |
265.90 | 171.40 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor1 | 11536-120A6 |
70.32 | 41.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor2 | 11616-122A5 |
47.49 | 34.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor3 | 11697-123A5 |
39.49 | 27.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor4 | 11464-119B6 |
479.65 | 162.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - hepatic, donor1 | 11538-120A8 |
49.81 | 30.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - hepatic, donor2 | 11618-122A7 |
380.91 | 204.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - umbilical, donor1 | 11539-120A9 |
76.86 | 26.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - umbilical, donor2 | 11619-122A8 |
60.72 | 23.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal Stem Cells - umbilical, donor3 | 11700-123A8 |
72.37 | 42.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal stem cells - adipose, donor0 | 11217-116B2 |
463.26 | 311.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal stem cells - hepatic, donor0 | 11218-116B3 |
370.89 | 190.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesenchymal stem cells - umbilical, donor0 | 11214-116A8 |
417.27 | 289.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesothelial Cells, donor1 | 11247-116E5 |
182.44 | 141.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesothelial Cells, donor2 | 12156-128G5 |
169.66 | 148.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mesothelial Cells, donor3 | 11402-118D7 |
143.37 | 89.75 | 0.14 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1) | 12698-135D7 |
63.47 | 28.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 12796-136F6 |
173.62 | 80.78 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3) | 12894-137H5 |
160.77 | 86.28 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1) | 12699-135D8 |
24.20 | 6.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2) | 12797-136F7 |
161.48 | 83.38 | 1.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3) | 12895-137H6 |
144.37 | 80.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1) | 12700-135D9 |
13.90 | 11.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2) | 12798-136F8 |
150.91 | 81.84 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3) | 12896-137H7 |
131.73 | 60.98 | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1) | 12701-135E1 |
38.93 | 19.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2) | 12799-136F9 |
150.79 | 66.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3) | 12897-137H8 |
116.81 | 70.88 | 0.00 | 0.00 | 0.40 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1) | 12702-135E2 |
8.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2) | 12800-136G1 |
133.63 | 65.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3) | 12898-137H9 |
187.69 | 112.84 | 1.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1) | 12703-135E3 |
25.00 | 6.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2) | 12801-136G2 |
158.11 | 75.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3) | 12899-137I1 |
48.80 | 21.18 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1) | 12704-135E4 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2) | 12802-136G3 |
91.21 | 47.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3) | 12900-137I2 |
31.86 | 18.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1) | 12705-135E5 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2) | 12803-136G4 |
130.97 | 82.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3) | 12901-137I3 |
123.11 | 68.21 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1) | 12706-135E6 |
35.38 | 12.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2) | 12804-136G5 |
119.27 | 84.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3) | 12902-137I4 |
133.36 | 75.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1) | 12707-135E7 |
92.54 | 48.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2) | 12805-136G6 |
137.73 | 84.31 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3) | 12903-137I5 |
89.81 | 51.79 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1) | 12708-135E8 |
0.00 | 10.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2) | 12806-136G7 |
93.52 | 51.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3) | 12904-137I6 |
59.82 | 34.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1) | 12709-135E9 |
18.23 | 9.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2) | 12807-136G8 |
91.59 | 44.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3) | 12905-137I7 |
99.69 | 59.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1) | 12710-135F1 |
21.81 | 8.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2) | 12808-136G9 |
94.67 | 48.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3) | 12906-137I8 |
117.27 | 66.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 12711-135F2 |
27.42 | 8.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2) | 12809-136H1 |
89.10 | 52.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3) | 12907-137I9 |
107.79 | 134.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1) | 12712-135F3 |
12.23 | 4.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2) | 12810-136H2 |
99.41 | 57.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3) | 12908-138A1 |
28.69 | 15.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1) | 12713-135F4 |
26.90 | 9.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2) | 12811-136H3 |
96.69 | 59.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3) | 12909-138A2 |
41.75 | 18.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1) | 12714-135F5 |
15.47 | 4.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2) | 12812-136H4 |
90.60 | 50.94 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3) | 12910-138A3 |
40.26 | 18.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1) | 12715-135F6 |
25.57 | 7.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2) | 12813-136H5 |
90.62 | 56.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3) | 12911-138A4 |
48.21 | 25.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1) | 12716-135F7 |
18.07 | 9.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2) | 12814-136H6 |
53.39 | 27.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3) | 12912-138A5 |
88.90 | 55.10 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1) | 12717-135F8 |
14.44 | 14.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2) | 12815-136H7 |
43.41 | 29.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3) | 12913-138A6 |
85.94 | 56.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1) | 12718-135F9 |
50.57 | 22.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2) | 12816-136H8 |
74.38 | 55.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3) | 12914-138A7 |
58.34 | 40.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1) | 12719-135G1 |
17.15 | 8.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2) | 12817-136H9 |
46.44 | 26.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 12915-138A8 |
99.98 | 55.68 | 0.00 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1) | 12720-135G2 |
48.87 | 21.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2) | 12818-136I1 |
85.68 | 61.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3) | 12916-138A9 |
93.98 | 61.03 | 0.22 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1) | 12721-135G3 |
36.02 | 14.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2) | 12819-136I2 |
100.57 | 73.87 | 0.28 | 0.00 | 0.00 | 0.28 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3) | 12917-138B1 |
123.64 | 86.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1) | 12722-135G4 |
24.76 | 9.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2) | 12820-136I3 |
80.86 | 54.98 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3) | 12918-138B2 |
125.71 | 71.50 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1) | 12723-135G5 |
126.53 | 49.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2) | 12821-136I4 |
82.19 | 42.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 13304-142I1 |
135.61 | 52.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h) | 13316-143A4 |
115.85 | 64.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h) | 13322-143B1 |
139.97 | 95.61 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h) | 13310-142I7 |
83.10 | 45.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h) | 13309-142I6 |
112.88 | 46.65 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h) | 13321-143A9 |
107.10 | 37.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h) | 13327-143B6 |
119.79 | 67.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h) | 13315-143A3 |
86.29 | 44.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h) | 13305-142I2 |
145.79 | 96.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h) | 13317-143A5 |
94.30 | 38.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h) | 13323-143B2 |
113.96 | 75.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h) | 13311-142I8 |
93.34 | 45.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h) | 13306-142I3 |
209.50 | 129.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h) | 13318-143A6 |
115.92 | 42.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h) | 13324-143B3 |
88.87 | 57.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h) | 13312-142I9 |
91.50 | 51.02 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h) | 13307-142I4 |
234.25 | 134.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h) | 13319-143A7 |
292.47 | 115.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h) | 13325-143B4 |
336.89 | 208.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h) | 13313-143A1 |
95.16 | 72.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h) | 13308-142I5 |
22.84 | 11.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h) | 13320-143A8 |
218.58 | 130.50 | 6.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h) | 13326-143B5 |
52.28 | 28.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h) | 13314-143A2 |
37.65 | 12.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1 | 11549-120C1 |
241.93 | 175.15 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2 | 11629-122B9 |
223.68 | 112.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1 | 13496-145C4 |
56.07 | 32.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2 | 13505-145D4 |
27.55 | 14.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3 | 13514-145E4 |
173.60 | 117.70 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor1 | 13469-144I4 |
161.18 | 106.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor2 | 13478-145A4 |
27.88 | 14.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor3 | 13487-145B4 |
391.42 | 321.59 | 1.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 13497-145C5 |
48.13 | 31.81 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2 | 13506-145D5 |
68.34 | 43.00 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3 | 13515-145E5 |
49.18 | 26.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day01, control donor1 | 13470-144I5 |
128.45 | 79.05 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day01, control donor2 | 13479-145A5 |
779.43 | 690.35 | 11.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day01, control donor3 | 13488-145B5 |
92.82 | 42.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 13498-145C6 |
96.36 | 58.19 | 1.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2 | 13507-145D6 |
59.62 | 33.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3 | 13516-145E6 |
51.77 | 23.68 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day02, control donor1 | 13471-144I6 |
198.29 | 102.25 | 0.00 | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day02, control donor2 | 13480-145A6 |
90.17 | 35.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day02, control donor3 | 13489-145B6 |
64.23 | 21.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1 | 13499-145C7 |
245.15 | 140.46 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2 | 13508-145D7 |
49.11 | 19.68 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day03, control donor1 | 13472-144I7 |
140.93 | 79.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day03, control donor2 | 13481-145A7 |
68.92 | 27.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day03, control donor3 | 13490-145B7 |
62.98 | 17.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1 | 13500-145C8 |
72.95 | 36.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 13509-145D8 |
236.94 | 112.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3 | 13518-145E8 |
414.67 | 144.12 | 2.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day04, control donor1 | 13473-144I8 |
109.39 | 57.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day04, control donor2 | 13482-145A8 |
51.65 | 20.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day04, control donor3 | 13491-145B8 |
73.34 | 39.16 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 13501-145C9 |
77.26 | 38.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 13510-145D9 |
893.75 | 541.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3 | 13519-145E9 |
73.64 | 27.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day06, control donor1 | 13474-144I9 |
55.91 | 37.87 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day06, control donor2 | 13483-145A9 |
56.35 | 32.93 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day06, control donor3 | 13492-145B9 |
56.65 | 36.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1 | 13502-145D1 |
93.46 | 40.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2 | 13511-145E1 |
41.39 | 17.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3 | 13520-145F1 |
31.38 | 17.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day08, control donor1 | 13475-145A1 |
98.60 | 62.42 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day08, control donor2 | 13484-145B1 |
44.10 | 30.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day08, control donor3 | 13493-145C1 |
49.20 | 27.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1 | 13503-145D2 |
69.94 | 34.23 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 13512-145E2 |
26.03 | 13.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3 | 13521-145F2 |
146.08 | 81.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day10, control donor1 | 13476-145A2 |
108.08 | 70.95 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day10, control donor2 | 13485-145B2 |
48.11 | 31.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day10, control donor3 | 13494-145C2 |
388.32 | 327.01 | 5.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 13504-145D3 |
72.55 | 46.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2 | 13513-145E3 |
28.96 | 13.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 13522-145F3 |
39.34 | 19.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day12, control donor1 | 13477-145A3 |
66.46 | 26.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day12, control donor2 | 13486-145B3 |
158.71 | 125.83 | 0.00 | 0.00 | 1.13 | 0.00 | 0.00 | 0.00 |
Myoblast differentiation to myotubes, day12, control donor3 | 13495-145C3 |
627.18 | 455.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast, donor1 | 11241-116D8 |
208.46 | 183.73 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast, donor2 | 11322-117D8 |
281.74 | 144.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Myoblast, donor3 | 11398-118D3 |
243.50 | 151.01 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NK T cell leukemia cell line:KHYG-1 | 10777-110G3 |
497.78 | 206.20 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Natural Killer Cells, donor1 | 11230-116C6 |
262.93 | 47.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Natural Killer Cells, donor2 | 11311-117C6 |
271.40 | 32.27 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Natural Killer Cells, donor3 | 11387-118C1 |
277.19 | 33.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neural stem cells, donor1 | 11275-116H6 |
395.60 | 458.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neural stem cells, donor2 | 11352-117H2 |
267.66 | 269.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neurons, donor1 | 11494-119E9 |
443.78 | 262.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neurons, donor2 | 11574-120E8 |
307.13 | 235.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neurons, donor3 | 11655-122E8 |
322.29 | 177.59 | 4.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neutrophils, donor1 | 11233-116C9 |
1.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neutrophils, donor2 | 11314-117C9 |
0.00 | 2.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Neutrophils, donor3 | 11390-118C4 |
20.16 | 3.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Nucleus Pulposus Cell, donor1 | 11252-116F1 |
434.57 | 91.07 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 |
Nucleus Pulposus Cell, donor2 | 11409-118E5 |
305.42 | 91.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Nucleus Pulposus Cell, donor3 | 11462-119B4 |
403.31 | 99.47 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Olfactory epithelial cells, donor1 | 11933-125I7 |
132.83 | 49.14 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Olfactory epithelial cells, donor2 | 11934-125I8 |
179.19 | 91.19 | 0.14 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 |
Olfactory epithelial cells, donor3 | 11935-125I9 |
154.03 | 69.81 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Olfactory epithelial cells, donor4 | 11936-126A1 |
128.17 | 54.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Oligodendrocyte - precursors, donor1 | 11496-119F2 |
330.40 | 211.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Osteoblast - differentiated, donor1 | 11276-116H7 |
133.57 | 53.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Osteoblast - differentiated, donor2 | 11353-117H3 |
84.59 | 32.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Osteoblast - differentiated, donor3 | 11425-118G3 |
192.42 | 40.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Osteoblast, donor1 | 11277-116H8 |
101.24 | 63.13 | 0.00 | 0.00 | 0.20 | 0.00 | 0.00 | 0.00 |
Osteoblast, donor2 | 11354-117H4 |
358.88 | 254.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Osteoblast, donor3 | 11426-118G4 |
224.47 | 96.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pancreatic stromal cells, donor1 | 11249-116E7 |
337.70 | 188.27 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pericytes, donor1 | 11491-119E6 |
39.94 | 17.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pericytes, donor2 | 11571-120E5 |
28.97 | 10.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pericytes, donor3 | 11652-122E5 |
57.78 | 23.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Perineurial Cells, donor1 | 11499-119F5 |
390.71 | 242.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Perineurial Cells, donor2 | 11579-120F4 |
407.98 | 234.26 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Peripheral Blood Mononuclear Cells, donor1 | 11231-116C7 |
345.19 | 118.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Peripheral Blood Mononuclear Cells, donor2 | 11312-117C7 |
214.01 | 43.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Peripheral Blood Mononuclear Cells, donor3 | 11388-118C2 |
212.50 | 40.90 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Placental Epithelial Cells, donor1 | 11278-116H9 |
39.94 | 28.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Placental Epithelial Cells, donor2 | 11355-117H5 |
105.34 | 58.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Placental Epithelial Cells, donor3 | 11427-118G5 |
95.02 | 37.11 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - breast donor2 (cytoplasmic fraction) | 14319-155D8 |
57.28 | 32.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - breast, donor1 | 11467-119B9 |
138.06 | 102.99 | 0.19 | 0.00 | 0.19 | 0.00 | 0.00 | 0.00 |
Preadipocyte - breast, donor2 (nuclear fraction) | 14320-155D9 |
146.32 | 111.47 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - breast, donor2 | 11328-117E5 |
152.65 | 67.99 | 0.00 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 |
Preadipocyte - omental, donor1 | 11468-119C1 |
182.96 | 150.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - omental, donor2 | 11329-117E6 |
138.80 | 111.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - omental, donor3 | 11403-118D8 |
149.27 | 104.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - perirenal, donor1 | 11469-119C2 |
162.40 | 80.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - subcutaneous, donor1 | 11279-116I1 |
87.84 | 56.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - subcutaneous, donor2 | 11356-117H6 |
483.60 | 292.89 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - subcutaneous, donor3 | 11428-118G6 |
447.17 | 213.37 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - visceral, donor1 | 11280-116I2 |
471.42 | 359.08 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - visceral, donor2 | 11357-117H7 |
417.38 | 289.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preadipocyte - visceral, donor3 | 11429-118G7 |
399.89 | 237.19 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Prostate Epithelial Cells (polarized), donor1 | 11253-116F2 |
539.90 | 686.08 | 0.00 | 0.00 | 0.45 | 0.00 | 0.00 | 0.00 |
Prostate Epithelial Cells, donor2 | 11331-117E8 |
147.19 | 90.86 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Prostate Epithelial Cells, donor3 | 11404-118D9 |
114.94 | 37.29 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Prostate Stromal Cells, donor1 | 11254-116F3 |
348.54 | 249.33 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Prostate Stromal Cells, donor2 | 11332-117E9 |
355.37 | 205.66 | 0.00 | 0.18 | 0.00 | 0.18 | 0.00 | 0.00 |
Prostate Stromal Cells, donor3 | 11405-118E1 |
284.78 | 114.91 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Cortical Epithelial Cells, donor1 | 11516-119H4 |
61.32 | 43.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Cortical Epithelial Cells, donor2 | 11596-120H3 |
355.85 | 219.09 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Epithelial Cells, donor1 | 11517-119H5 |
27.39 | 16.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Epithelial Cells, donor2 | 11597-120H4 |
54.06 | 47.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Epithelial Cells, donor3 | 11678-122H4 |
502.12 | 332.73 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Glomerular Endothelial Cells, donor1 | 11514-119H2 |
17.70 | 7.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Glomerular Endothelial Cells, donor2 | 11594-120H1 |
63.07 | 32.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Glomerular Endothelial Cells, donor3 | 11675-122H1 |
282.62 | 216.24 | 0.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Glomerular Endothelial Cells, donor4 | 11783-124B1 |
16.64 | 10.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Mesangial Cells, donor1 | 11518-119H6 |
68.67 | 55.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Mesangial Cells, donor2 | 11598-120H5 |
63.33 | 64.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Mesangial Cells, donor3 | 11679-122H5 |
36.06 | 20.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Proximal Tubular Epithelial Cell, donor1 | 11515-119H3 |
157.56 | 85.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Proximal Tubular Epithelial Cell, donor2 | 11595-120H2 |
66.21 | 29.10 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Renal Proximal Tubular Epithelial Cell, donor3 | 11676-122H2 |
80.03 | 55.93 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retinal Pigment Epithelial Cells, donor0 | 11215-116A9 |
666.10 | 465.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retinal Pigment Epithelial Cells, donor1 | 11528-119I7 |
107.44 | 59.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retinal Pigment Epithelial Cells, donor2 | 11608-120I6 |
75.13 | 55.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Retinal Pigment Epithelial Cells, donor3 | 11689-122I6 |
649.60 | 278.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SABiosciences XpressRef Human Universal Total RNA, pool1 | 10002-101A5 |
123.88 | 112.79 | 0.27 | 0.13 | 0.00 | 0.13 | 1.47 | 0.40 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17) | 12697-135D6 |
263.55 | 150.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17) | 12795-136F5 |
542.67 | 346.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17) | 12893-137H4 |
251.16 | 190.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0) | 12662-134I7 |
407.63 | 317.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0) | 12760-136B6 |
279.35 | 204.67 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0) | 12858-137D5 |
542.41 | 438.79 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1) | 12663-134I8 |
632.99 | 428.69 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1) | 12761-136B7 |
323.88 | 243.70 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1) | 12859-137D6 |
483.99 | 388.76 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2) | 12664-134I9 |
245.89 | 210.70 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2) | 12762-136B8 |
350.05 | 269.27 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 12860-137D7 |
411.24 | 349.78 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3) | 12665-135A1 |
294.66 | 244.59 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 12763-136B9 |
333.32 | 247.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3) | 12861-137D8 |
386.12 | 300.71 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4) | 12666-135A2 |
223.49 | 214.88 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4) | 12764-136C1 |
287.41 | 204.03 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4) | 12862-137D9 |
515.81 | 470.14 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5) | 12667-135A3 |
244.45 | 178.36 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5) | 12765-136C2 |
321.32 | 224.37 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5) | 12863-137E1 |
420.87 | 304.96 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6) | 12668-135A4 |
291.76 | 229.39 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6) | 12766-136C3 |
337.21 | 233.49 | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6) | 12864-137E2 |
346.41 | 246.61 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7) | 12669-135A5 |
241.04 | 204.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7) | 12767-136C4 |
266.60 | 202.47 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7) | 12865-137E3 |
400.14 | 270.79 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8) | 12670-135A6 |
328.10 | 372.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8) | 12768-136C5 |
305.56 | 213.29 | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8) | 12866-137E4 |
459.51 | 311.02 | 0.23 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9) | 12671-135A7 |
269.56 | 246.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9) | 12769-136C6 |
441.09 | 301.95 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9) | 12867-137E5 |
297.45 | 219.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10) | 12672-135A8 |
280.21 | 233.24 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10) | 12770-136C7 |
252.21 | 189.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10) | 12868-137E6 |
338.16 | 232.12 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11) | 12673-135A9 |
316.19 | 324.10 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11) | 12771-136C8 |
258.43 | 189.70 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11) | 12869-137E7 |
374.63 | 323.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12) | 12674-135B1 |
248.83 | 254.28 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12) | 12772-136C9 |
354.80 | 277.12 | 0.15 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12) | 12870-137E8 |
280.94 | 226.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13) | 12675-135B2 |
337.37 | 159.70 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13) | 12773-136D1 |
450.25 | 262.39 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13) | 12871-137E9 |
357.74 | 228.95 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14) | 12676-135B3 |
368.97 | 226.21 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14) | 12774-136D2 |
479.67 | 193.20 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14) | 12872-137F1 |
334.55 | 149.29 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15) | 12677-135B4 |
375.12 | 266.19 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 12775-136D3 |
609.14 | 366.21 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15) | 12873-137F2 |
470.31 | 245.20 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16) | 12678-135B5 |
353.54 | 283.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16) | 12776-136D4 |
295.40 | 149.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16) | 12874-137F3 |
380.12 | 195.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17) | 12679-135B6 |
326.48 | 183.72 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17) | 12777-136D5 |
292.21 | 154.53 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17) | 12875-137F4 |
326.93 | 182.10 | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Schwann Cells, donor1 | 11498-119F4 |
54.54 | 19.94 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Schwann Cells, donor2 | 11578-120F3 |
323.23 | 193.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Schwann Cells, donor3 | 11659-122F3 |
311.97 | 204.62 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sebocyte, donor1 | 11220-116B5 |
172.55 | 121.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sebocyte, donor2 | 11301-117B5 |
177.39 | 121.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sebocyte, donor3 | 11378-118B1 |
116.25 | 59.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sertoli Cells, donor1 | 11255-116F4 |
271.68 | 170.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sertoli Cells, donor2 | 11333-117F1 |
338.92 | 163.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Cells, donor1 | 11281-116I3 |
321.56 | 124.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Cells, donor2 | 11358-117H8 |
83.85 | 36.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Cells, donor3 | 11430-118G8 |
182.26 | 97.82 | 0.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Cells, donor4 | 11451-119A2 |
570.88 | 325.81 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Cells, donor5 | 11455-119A6 |
526.20 | 287.03 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Cells, donor6 | 11459-119B1 |
588.68 | 309.19 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Satellite Cells, donor1 | 11240-116D7 |
607.98 | 294.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Satellite Cells, donor2 | 11321-117D7 |
443.76 | 173.65 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal Muscle Satellite Cells, donor3 | 11397-118D2 |
496.55 | 254.87 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1 | 11282-116I4 |
318.89 | 214.34 | 0.17 | 0.00 | 0.08 | 0.00 | 0.00 | 0.00 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2 | 11359-117H9 |
125.21 | 52.11 | 0.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3 | 11431-118G9 |
121.64 | 54.49 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 |
Skin - palm, donor1 | 10286-104F7 |
21.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Small Airway Epithelial Cells donor2 (cytoplasmic fraction) | 14334-155F5 |
74.96 | 45.99 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Small Airway Epithelial Cells donor2 (nuclear fraction) | 14335-155F6 |
85.06 | 94.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Small Airway Epithelial Cells donor3 (cytoplasmic fraction) | 14316-155D5 |
97.37 | 56.86 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Small Airway Epithelial Cells, donor1 | 11256-116F5 |
233.81 | 88.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Small Airway Epithelial Cells, donor2 | 11334-117F2 |
118.29 | 32.77 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Small Airway Epithelial Cells, donor3 (nuclear fraction) | 14317-155D6 |
237.67 | 143.99 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Small Airway Epithelial Cells, donor3 | 11406-118E2 |
59.51 | 18.36 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction) | 14313-155D2 |
206.75 | 154.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction) | 14314-155D3 |
151.19 | 128.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Aortic, donor0 | 11210-116A4 |
166.94 | 93.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Aortic, donor1 | 11283-116I5 |
116.24 | 54.81 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Aortic, donor2 | 11360-117I1 |
111.05 | 76.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Aortic, donor3 | 11432-118H1 |
172.28 | 101.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Bladder, donor1 | 11519-119H7 |
458.35 | 136.10 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Brachiocephalic, donor1 | 11284-116I6 |
130.55 | 85.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Brachiocephalic, donor2 | 11361-117I2 |
353.54 | 185.30 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Brachiocephalic, donor3 | 11433-118H2 |
183.08 | 141.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Brain Vascular, donor1 | 11234-116D1 |
378.99 | 288.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Brain Vascular, donor2 | 11315-117D1 |
347.01 | 235.96 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Brain Vascular, donor3 | 11391-118C5 |
234.33 | 127.13 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Bronchial, donor1 | 11512-119G9 |
19.85 | 10.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Bronchial, donor2 | 11592-120G8 |
203.06 | 75.50 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Carotid, donor1 | 11285-116I7 |
119.46 | 63.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Carotid, donor2 | 11362-117I3 |
36.72 | 36.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Carotid, donor3 | 11434-118H3 |
92.03 | 41.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Colonic, donor1 | 11239-116D6 |
346.71 | 233.60 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Colonic, donor2 | 11320-117D6 |
309.94 | 184.03 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Colonic, donor3 | 11396-118D1 |
397.58 | 204.67 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Coronary Artery, donor1 | 11286-116I8 |
100.70 | 76.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Coronary Artery, donor2 | 11363-117I4 |
141.20 | 108.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Coronary Artery, donor3 | 11435-118H4 |
164.37 | 89.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Esophageal, donor1 | 11508-119G5 |
55.99 | 33.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Esophageal, donor2 | 11588-120G4 |
504.55 | 225.54 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Internal Thoracic Artery, donor1 | 11287-116I9 |
177.93 | 132.95 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2 | 11364-117I5 |
157.47 | 106.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3 | 11436-118H5 |
141.90 | 71.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Intestinal, donor1 | 11509-119G6 |
604.56 | 399.77 | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Prostate, donor1 | 11257-116F6 |
329.30 | 190.55 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Prostate, donor2 | 11335-117F3 |
316.43 | 152.52 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Prostate, donor3 | 11465-119B7 |
268.37 | 92.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Pulmonary Artery, donor1 | 11288-117A1 |
220.58 | 148.66 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Pulmonary Artery, donor2 | 11365-117I6 |
105.02 | 48.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Pulmonary Artery, donor3 | 11437-118H6 |
465.20 | 45.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor1 | 11289-117A2 |
133.48 | 77.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor2 | 11366-117I7 |
202.96 | 124.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor3 | 11438-118H7 |
97.15 | 66.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Tracheal, donor1 | 11513-119H1 |
40.71 | 19.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Tracheal, donor2 | 11593-120G9 |
428.78 | 261.08 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Tracheal, donor3 | 11674-122G9 |
301.32 | 110.25 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Umbilical Artery, donor1 | 11290-117A3 |
96.86 | 59.73 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Umbilical Artery, donor2 | 11367-117I8 |
163.17 | 76.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Umbilical Artery, donor3 | 11439-118H8 |
116.39 | 72.02 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Umbilical Vein, donor1 | 11541-120B2 |
447.32 | 242.60 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Umbilical Vein, donor2 | 11621-122B1 |
337.67 | 147.47 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Umbilical Vein, donor3 | 11702-123B1 |
34.76 | 11.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Umbilical artery, donor0 | 11212-116A6 |
103.49 | 57.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Uterine, donor1 | 11258-116F7 |
280.16 | 150.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth Muscle Cells - Uterine, donor3 | 11466-119B8 |
327.40 | 182.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor1 | 11960-126C7 |
134.30 | 69.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor2 | 11961-126C8 |
109.75 | 101.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor3 | 11962-126C9 |
291.98 | 187.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor4 | 11963-126D1 |
166.37 | 149.48 | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor5 | 11964-126D2 |
155.01 | 158.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor6 | 11965-126D3 |
210.33 | 179.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, control, donor1 | 11966-126D4 |
169.13 | 123.42 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, control, donor2 | 11967-126D5 |
172.91 | 60.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, control, donor3 | 11968-126D6 |
143.38 | 110.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Smooth muscle cells - airway, control, donor4 | 11969-126D7 |
186.09 | 74.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Synoviocyte, donor1 | 11291-117A4 |
136.68 | 95.10 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Synoviocyte, donor2 | 11368-117I9 |
239.20 | 91.69 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Synoviocyte, donor3 | 11440-118H9 |
207.10 | 57.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Trabecular Meshwork Cells, donor1 | 11532-120A2 |
73.97 | 56.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Trabecular Meshwork Cells, donor2 | 11612-122A1 |
37.66 | 23.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Trabecular Meshwork Cells, donor3 | 11693-123A1 |
61.59 | 23.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tracheal Epithelial Cells, donor1 | 11292-117A5 |
253.76 | 127.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tracheal Epithelial Cells, donor2 | 11369-118A1 |
121.77 | 56.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tracheal Epithelial Cells, donor3 | 11441-118I1 |
105.37 | 45.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Universal RNA - Human Normal Tissues Biochain, pool1 | 10007-101B4 |
134.71 | 115.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.98 | 1.23 |
Urethra, donor2 | 10319-105A4 |
73.74 | 53.95 | 1.80 | 0.00 | 0.00 | 1.80 | 0.00 | 0.00 |
Urothelial Cells, donor1 | 11520-119H8 |
25.50 | 9.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Urothelial Cells, donor2 | 11600-120H7 |
31.24 | 18.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Urothelial Cells, donor3 | 11681-122H7 |
25.21 | 10.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Urothelial cells, donor0 | 11216-116B1 |
242.51 | 94.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090309, donation1 | 12179-129A1 |
361.25 | 165.50 | 0.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090309, donation2 | 12180-129A2 |
378.85 | 204.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090309, donation3 | 12181-129A3 |
168.39 | 81.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090325, donation1 | 12176-128I7 |
300.95 | 156.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090325, donation2 | 12177-128I8 |
334.09 | 175.47 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090612, donation1 | 12182-129A4 |
306.12 | 134.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090612, donation2 | 12183-129A5 |
385.47 | 176.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Whole blood (ribopure), donor090612, donation3 | 12184-129A6 |
194.45 | 82.16 | 0.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Wilms' tumor cell line:G-401 | 10809-111A8 |
400.92 | 297.79 | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Wilms' tumor cell line:HFWT | 10597-108E3 |
183.93 | 58.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acantholytic squamous carcinoma cell line:HCC1806 | 10717-109I6 |
441.60 | 168.71 | 0.28 | 0.00 | 0.28 | 0.00 | 0.00 | 0.00 |
achilles tendon, donor2 | 10292-104G4 |
101.26 | 43.40 | 4.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1 | 10455-106G5 |
613.42 | 429.86 | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6 | 10534-107G3 |
834.44 | 415.59 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL | 10429-106D6 |
636.27 | 386.99 | 0.47 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat | 10464-106H5 |
822.60 | 678.38 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M0) cell line:KG-1 | 10827-111C8 |
339.27 | 296.26 | 0.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3 | 10789-110H6 |
365.86 | 261.60 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M1) cell line:HYT-1 | 10828-111C9 |
611.39 | 206.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1 | 10788-110H5 |
1239.52 | 562.26 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6 | 10792-110H9 |
347.92 | 172.74 | 0.00 | 0.00 | 0.41 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M2) cell line:NKM-1 | 10765-110E9 |
557.21 | 194.54 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M3) cell line:HL60 | 10829-111D1 |
731.03 | 361.19 | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M4) cell line:FKH-1 | 10830-111D2 |
772.30 | 230.13 | 0.00 | 0.00 | 0.00 | 3.90 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M4) cell line:HNT-34 | 10831-111D3 |
664.38 | 460.81 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1 | 10832-111D4 |
808.29 | 571.91 | 0.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3 | 10833-111D5 |
728.86 | 446.26 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1 | 10764-110E8 |
282.57 | 182.19 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ | 10770-110F5 |
428.11 | 291.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction) | 14298-155B5 |
112.04 | 73.98 | 1.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh) | 10399-106A3 |
504.37 | 366.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived) | 10400-106A4 |
566.86 | 331.50 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed) | 10405-106A9 |
612.36 | 419.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4 | 10834-111D6 |
444.59 | 359.72 | 0.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M6) cell line:EEB | 10835-111D7 |
345.89 | 241.82 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M6) cell line:F-36E | 10836-111D8 |
511.01 | 314.04 | 0.00 | 0.00 | 0.00 | 1.86 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M6) cell line:F-36P | 10837-111D9 |
710.38 | 613.58 | 1.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M7) cell line:M-MOK | 10699-109G6 |
595.32 | 243.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1 | 10802-111A1 |
316.78 | 161.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adenocarcinoma cell line:IM95m | 10796-110I4 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adipose tissue, adult, pool1 | 10010-101C1 |
179.47 | 209.88 | 0.31 | 0.31 | 0.31 | 0.00 | 0.00 | 0.00 |
adipose, donor1 | 10184-103D4 |
1161.68 | 439.22 | 1.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adipose, donor2 | 10185-103D5 |
236.42 | 82.73 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adipose, donor3 | 10186-103D6 |
373.85 | 211.30 | 1.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adipose, donor4 | 10187-103D7 |
618.86 | 492.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adrenal cortex adenocarcinoma cell line:SW-13 | 10810-111A9 |
411.44 | 152.93 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adrenal gland, adult, pool1 | 10081-102A9 |
94.58 | 43.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
adult T-cell leukemia cell line:ATN-1 | 10421-106C7 |
169.16 | 59.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
alveolar cell carcinoma cell line:SW 1573 | 10708-109H6 |
515.58 | 301.92 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
amniotic membrane cells, donor1 | 12235-129G3 |
10.43 | 5.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
amniotic membrane cells, donor2 | 12236-129G4 |
61.87 | 18.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
amniotic membrane cells, donor3 | 12237-129G5 |
11.19 | 2.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
amygdala - adult, donor10196 | 10167-103B5 |
269.18 | 337.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
amygdala, adult, donor10252 | 10151-102I7 |
255.28 | 297.46 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
amygdala, newborn, donor10223 | 10360-105E9 |
138.15 | 142.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
anaplastic carcinoma cell line:8305C | 10428-106D5 |
306.36 | 105.17 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
anaplastic large cell lymphoma cell line:Ki-JK | 10795-110I3 |
726.51 | 447.20 | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
anaplastic squamous cell carcinoma cell line:RPMI 2650 | 10805-111A4 |
736.89 | 237.50 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
aorta, adult, pool1 | 10052-101G7 |
97.09 | 26.87 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
appendix, adult | 10189-103D9 |
174.26 | 91.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
argyrophil small cell carcinoma cell line:TC-YIK | 10589-108D4 |
442.99 | 83.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
artery, adult | 10190-103E1 |
112.77 | 105.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
astrocytoma cell line:TM-31 | 10425-106D2 |
521.67 | 216.87 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b cell line:RPMI1788 | 10427-106D4 |
622.17 | 177.10 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
basal cell carcinoma cell line:TE 354.T | 10702-109G9 |
134.01 | 76.02 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bile duct carcinoma cell line:HuCCT1 | 10432-106D9 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bile duct carcinoma cell line:TFK-1 | 10496-107C1 |
332.75 | 247.39 | 0.50 | 0.67 | 1.67 | 1.00 | 0.00 | 0.00 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11 | 10718-109I7 |
411.04 | 120.24 | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bladder, adult, pool1 | 10011-101C2 |
235.53 | 93.76 | 0.11 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
blood, adult, pool1 | 10053-101G8 |
181.60 | 53.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bone marrow stromal cell line:StromaNKtert | 10686-109F2 |
122.46 | 71.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bone marrow, adult | 10192-103E3 |
283.43 | 201.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
brain, adult, donor1 | 10084-102B3 |
206.04 | 206.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
brain, adult, pool1 | 10012-101C3 |
348.22 | 322.94 | 0.33 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
brain, fetal, pool1 | 10085-102B4 |
192.34 | 66.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
breast carcinoma cell line:MCF7 | 10482-107A5 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
breast carcinoma cell line:MDA-MB-453 | 10419-106C5 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
breast, adult, donor1 | 10080-102A8 |
83.34 | 80.18 | 1.26 | 1.26 | 1.26 | 0.00 | 0.00 | 0.00 |
bronchial squamous cell carcinoma cell line:KNS-62 | 10760-110E4 |
785.86 | 371.46 | 0.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bronchioalveolar carcinoma cell line:NCI-H358 | 10709-109H7 |
232.84 | 68.96 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bronchioalveolar carcinoma cell line:NCI-H650 | 10715-109I4 |
1562.04 | 369.96 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
bronchogenic carcinoma cell line:ChaGo-K-1 | 10710-109H8 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
carcinoid cell line:NCI-H1770 | 10703-109H1 |
552.92 | 255.30 | 0.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
carcinoid cell line:NCI-H727 | 10735-110B6 |
192.84 | 83.13 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
carcinoid cell line:SK-PN-DW | 10719-109I8 |
675.62 | 301.68 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
carcinosarcoma cell line:JHUCS-1 | 10642-109A3 |
930.82 | 237.16 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
caudate nucleus - adult, donor10196 | 10177-103C6 |
270.56 | 287.83 | 1.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
caudate nucleus, adult, donor10252 | 10164-103B2 |
294.16 | 287.97 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
caudate nucleus, adult, donor10258 | 10379-105H1 |
275.09 | 310.24 | 1.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
caudate nucleus, newborn, donor10223 | 10354-105E3 |
192.64 | 244.64 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cerebellum - adult, donor10196 | 10173-103C2 |
335.03 | 358.33 | 0.00 | 2.91 | 0.00 | 0.00 | 0.00 | 0.00 |
cerebellum, adult, donor10252 | 10166-103B4 |
298.70 | 367.24 | 0.64 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 |
cerebellum, adult, pool1 | 10083-102B2 |
269.75 | 213.18 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cerebellum, newborn, donor10223 | 10357-105E6 |
219.20 | 145.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cerebral meninges, adult | 10188-103D8 |
301.81 | 276.34 | 0.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cerebrospinal fluid, donor2 | 10294-104G6 |
122.06 | 73.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cervical cancer cell line:D98-AH2 | 10552-107I3 |
947.96 | 357.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cervical cancer cell line:ME-180 | 10553-107I4 |
461.35 | 211.12 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cervix, adult, pool1 | 10013-101C4 |
173.34 | 67.40 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cholangiocellular carcinoma cell line:HuH-28 | 10536-107G5 |
119.13 | 93.36 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chondrosarcoma cell line:SW 1353 | 10700-109G7 |
79.68 | 26.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
choriocarcinoma cell line:BeWo | 10423-106C9 |
945.24 | 496.36 | 0.75 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 |
choriocarcinoma cell line:SCH | 10785-110H2 |
393.54 | 177.92 | 0.37 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 |
choriocarcinoma cell line:T3M-3 | 10618-108G6 |
286.75 | 112.66 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chorionic membrane cells, donor1 | 12238-129G6 |
9.40 | 4.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chorionic membrane cells, donor2 | 12239-129G7 |
193.10 | 143.78 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chorionic membrane cells, donor3 | 12240-129G8 |
12.64 | 6.04 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 10416-106C2 |
751.29 | 594.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chronic myeloblastic leukemia (CML) cell line:KCL-22 | 10801-110I9 |
491.39 | 239.16 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chronic myelogenous leukemia (CML) cell line:MEG-A2 | 10766-110F1 |
447.50 | 211.82 | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1 | 10824-111C5 |
380.07 | 274.01 | 0.00 | 0.00 | 0.00 | 0.26 | 0.00 | 0.00 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2 | 10825-111C6 |
331.86 | 243.57 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3 | 10826-111C7 |
349.39 | 250.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chronic myelogenous leukemia cell line:K562 | 10454-106G4 |
680.78 | 413.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
chronic myelogenous leukemia cell line:KU812 | 10409-106B4 |
740.96 | 394.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
clear cell carcinoma cell line:JHOC-5 | 10638-108I8 |
827.24 | 328.24 | 0.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
clear cell carcinoma cell line:TEN | 10636-108I6 |
566.15 | 326.71 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
colon carcinoma cell line:CACO-2 | 10513-107D9 |
888.67 | 774.63 | 0.73 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 |
colon carcinoma cell line:COLO-320 | 10420-106C6 |
1527.93 | 534.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
colon, adult, donor1 | 10082-102B1 |
77.35 | 39.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
colon, adult, pool1 | 10014-101C5 |
122.44 | 55.34 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 |
colon, fetal, donor1 | 10070-101I7 |
121.74 | 46.35 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
common myeloid progenitor CMP, donor1 | 12130-128D6 |
123.76 | 32.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
common myeloid progenitor CMP, donor2 | 12134-128E1 |
976.43 | 350.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cord blood derived cell line:COBL-a 24h infection(-C) | 10452-106G2 |
394.34 | 219.69 | 0.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cord blood derived cell line:COBL-a 24h infection | 10453-106G3 |
548.03 | 418.38 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cord blood derived cell line:COBL-a untreated | 10449-106F8 |
624.26 | 477.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
corpus callosum, adult, pool1 | 10042-101F6 |
217.25 | 165.84 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
cruciate ligament, donor2 | 10295-104G7 |
93.20 | 55.92 | 0.00 | 0.81 | 0.00 | 0.00 | 0.00 | 0.00 |
diaphragm, fetal, donor1 | 10069-101I6 |
143.66 | 148.47 | 1.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
diencephalon, adult | 10193-103E4 |
277.67 | 321.34 | 0.96 | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 |
diffuse large B-cell lymphoma cell line:CTB-1 | 10631-108I1 |
1380.19 | 487.23 | 0.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ductal cell carcinoma cell line:KLM-1 | 10438-106E6 |
172.58 | 60.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ductal cell carcinoma cell line:MIA Paca2 | 10488-107B2 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ductus deferens, adult | 10196-103E7 |
87.71 | 41.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
duodenum, fetal, donor1, tech_rep1 | 10071-101I8 |
146.90 | 60.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
duodenum, fetal, donor1, tech_rep2 | 10071-101I8 |
207.45 | 122.85 | 2.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
dura mater, adult, donor1 | 10041-101F5 |
177.81 | 76.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr | 10451-106G1 |
374.19 | 233.18 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
embryonic kidney cell line: HEK293/SLAM untreated | 10450-106F9 |
647.26 | 616.45 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
embryonic pancreas cell line:1B2C6 | 10604-108F1 |
852.78 | 228.15 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
embryonic pancreas cell line:1C3D3 | 10605-108F2 |
1119.12 | 267.29 | 0.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
embryonic pancreas cell line:1C3IKEI | 10606-108F3 |
808.31 | 252.56 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
embryonic pancreas cell line:2C6 | 10603-108E9 |
795.96 | 219.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
endometrial carcinoma cell line:OMC-2 | 10497-107C2 |
260.45 | 149.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
endometrial stromal sarcoma cell line:OMC-9 | 10448-106F7 |
332.57 | 85.18 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
endometrioid adenocarcinoma cell line:JHUEM-1 | 10643-109A4 |
338.67 | 182.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
epidermoid carcinoma cell line:A431 | 10426-106D3 |
205.87 | 107.27 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
epidermoid carcinoma cell line:Ca Ski | 10431-106D8 |
101.74 | 52.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
epididymis, adult | 10197-103E8 |
167.45 | 91.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
epithelioid sarcoma cell line:HS-ES-1 | 10443-106F2 |
116.91 | 40.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
epithelioid sarcoma cell line:HS-ES-2R | 10495-107B9 |
93.20 | 51.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1 | 10815-111B5 |
596.93 | 321.33 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2 | 10816-111B6 |
508.44 | 241.42 | 0.30 | 0.10 | 0.10 | 0.00 | 0.00 | 0.00 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3 | 10817-111B7 |
545.25 | 295.20 | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
esophagus, adult, pool1 | 10015-101C6 |
138.46 | 70.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS | 10410-106B5 |
404.14 | 125.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
eye - muscle inferior rectus, donor1 | 10272-104E2 |
72.44 | 127.97 | 2.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
eye - muscle lateral, donor2 | 10298-104H1 |
149.40 | 330.36 | 6.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
eye - muscle medial, donor2 | 10299-104H2 |
87.80 | 171.14 | 2.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
eye - muscle superior, donor2 | 10297-104G9 |
116.94 | 159.36 | 8.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
eye - vitreous humor, donor1 | 10268-104D7 |
100.56 | 96.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
eye, fetal, donor1 | 10054-101G9 |
240.51 | 108.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
fibrosarcoma cell line:HT-1080 | 10758-110E2 |
445.45 | 172.72 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
fibrous histiocytoma cell line:GCT TIB-223 | 10711-109H9 |
385.57 | 174.50 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
frontal lobe, adult, pool1 | 10040-101F4 |
383.83 | 343.77 | 0.28 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
gall bladder carcinoma cell line:TGBC14TKB | 10470-106I2 |
209.27 | 180.15 | 1.20 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
gall bladder carcinoma cell line:TGBC2TKB | 10415-106C1 |
349.56 | 170.89 | 0.00 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
gall bladder, adult | 10198-103E9 |
141.48 | 69.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
gamma delta positive T cells, donor1 | 11937-126A2 |
280.24 | 92.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
gamma delta positive T cells, donor2 | 11938-126A3 |
154.63 | 57.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
gastric adenocarcinoma cell line:MKN1 | 10614-108G2 |
191.78 | 128.63 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
gastric adenocarcinoma cell line:MKN45 | 10612-108F9 |
614.87 | 181.81 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
gastric cancer cell line:AZ521 | 10549-107H9 |
644.34 | 432.51 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
gastric cancer cell line:GSS | 10560-108A2 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
gastrointestinal carcinoma cell line:ECC12 | 10615-108G3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
giant cell carcinoma cell line:LU65 | 10487-107B1 |
432.46 | 130.12 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
giant cell carcinoma cell line:Lu99B | 10433-106E1 |
1264.67 | 338.42 | 0.42 | 0.00 | 0.00 | 0.14 | 0.00 | 0.00 |
glassy cell carcinoma cell line:HOKUG | 10688-109F4 |
114.98 | 42.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
glioblastoma cell line:A172, tech_rep1 | 10444-106F3 |
176.17 | 132.68 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
glioblastoma cell line:A172, tech_rep2 | 10444-106F3 |
168.39 | 121.90 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
glioblastoma cell line:T98G | 10485-107A8 |
352.86 | 243.26 | 0.22 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
glioma cell line:GI-1 | 10413-106B8 |
352.04 | 177.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
globus pallidus - adult, donor10196 | 10175-103C4 |
220.13 | 257.31 | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
globus pallidus, adult, donor10252 | 10161-103A8 |
271.92 | 311.46 | 2.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
globus pallidus, adult, donor10258 | 10367-105F7 |
224.55 | 228.66 | 1.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
globus pallidus, newborn, donor10223 | 10364-105F4 |
168.93 | 225.42 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
granulocyte macrophage progenitor, donor1 | 12131-128D7 |
127.25 | 24.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
granulocyte macrophage progenitor, donor2 | 12135-128E2 |
448.06 | 142.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
granulocyte macrophage progenitor, donor3 | 12139-128E6 |
486.07 | 271.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
granulosa cell tumor cell line:KGN | 10624-108H3 |
148.48 | 76.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hIPS +CCl2, biol_rep1 | 14383-156B9 |
730.45 | 454.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hIPS +CCl2, biol_rep2 | 14384-156C1 |
668.06 | 522.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hIPS +CCl2, biol_rep3 | 14385-156C2 |
518.49 | 412.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hIPS, biol_rep1 | 14380-156B6 |
600.79 | 780.45 | 1.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hIPS, biol_rep2 | 14381-156B7 |
579.56 | 397.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hIPS, biol_rep3 | 14382-156B8 |
343.18 | 492.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hairy cell leukemia cell line:Mo | 10712-109I1 |
473.25 | 197.12 | 1.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
heart - mitral valve, adult | 10205-103F7 |
234.39 | 219.74 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
heart - pulmonic valve, adult | 10206-103F8 |
467.78 | 575.77 | 0.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
heart - tricuspid valve, adult | 10207-103F9 |
144.88 | 133.22 | 0.00 | 0.00 | 0.00 | 0.83 | 0.00 | 0.00 |
heart, adult, diseased post-infarction, donor1 | 10050-101G5 |
278.13 | 224.67 | 0.41 | 0.20 | 0.20 | 0.00 | 0.00 | 0.00 |
heart, adult, diseased, donor1 | 10051-101G6 |
505.89 | 635.77 | 0.00 | 0.00 | 0.43 | 0.00 | 0.00 | 0.00 |
heart, adult, pool1 | 10016-101C7 |
441.56 | 500.66 | 1.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
heart, fetal, pool1 | 10046-101G1 |
794.33 | 536.61 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hepatic mesenchymal tumor cell line:LI90 | 10778-110G4 |
126.49 | 47.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hepatoblastoma cell line:HuH-6 | 10633-108I3 |
419.78 | 152.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1 | 10818-111B8 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2 | 10819-111B9 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3 | 10820-111C1 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hepatoma cell line:Li-7 | 10484-107A7 |
456.76 | 430.52 | 1.67 | 4.89 | 9.45 | 3.45 | 0.00 | 0.00 |
hereditary spherocytic anemia cell line:WIL2-NS | 10808-111A7 |
649.43 | 405.42 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hippocampus - adult, donor10196 | 10169-103B7 |
238.47 | 293.36 | 0.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hippocampus, adult, donor10252 | 10153-102I9 |
304.52 | 373.91 | 2.86 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 |
hippocampus, adult, donor10258 | 10374-105G5 |
252.96 | 271.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
hippocampus, newborn, donor10223 | 10363-105F3 |
108.21 | 121.60 | 0.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1 | 13421-144D1 |
1694.31 | 1641.82 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2 | 13425-144D5 |
809.77 | 631.87 | 0.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3 | 13429-144D9 |
919.36 | 875.43 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1 | 13422-144D2 |
393.58 | 159.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2 | 13426-144D6 |
497.83 | 183.07 | 0.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3 | 13430-144E1 |
590.67 | 247.89 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1 | 13423-144D3 |
446.98 | 248.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2 | 13427-144D7 |
471.79 | 183.76 | 0.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3 | 13431-144E2 |
329.91 | 238.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1 | 13424-144D4 |
646.92 | 562.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2 | 13428-144D8 |
599.47 | 411.76 | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3 | 13432-144E3 |
708.31 | 543.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1 | 13433-144E4 |
814.81 | 581.97 | 1.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 13437-144E8 |
950.16 | 763.47 | 0.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3 | 13441-144F3 |
1522.08 | 1694.01 | 1.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1 | 13434-144E5 |
438.71 | 151.01 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 13438-144E9 |
412.96 | 143.03 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3 | 13442-144F4 |
528.25 | 249.38 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1 | 13435-144E6 |
445.55 | 142.80 | 1.13 | 0.00 | 0.00 | 0.19 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 13439-144F1 |
509.74 | 178.70 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3 | 13443-144F5 |
396.24 | 165.08 | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1 | 13436-144E7 |
426.05 | 291.98 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2 | 13440-144F2 |
425.30 | 264.47 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3 | 13444-144F6 |
313.57 | 220.90 | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1 | 13445-144F7 |
859.25 | 716.62 | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 13449-144G2 |
737.75 | 612.79 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3 | 13453-144G6 |
1152.66 | 1175.94 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 13446-144F8 |
514.39 | 285.54 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 13450-144G3 |
424.43 | 226.79 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3 | 13454-144G7 |
408.84 | 249.36 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1 | 13447-144F9 |
335.10 | 165.48 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 13451-144G4 |
368.61 | 209.21 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3 | 13455-144G8 |
335.03 | 241.40 | 0.51 | 0.00 | 0.26 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 13448-144G1 |
442.78 | 377.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2 | 13452-144G5 |
449.79 | 355.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 13456-144G9 |
361.60 | 378.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 13457-144H1 |
862.66 | 655.45 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 13461-144H5 |
909.14 | 1015.66 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3 | 13465-144H9 |
777.08 | 698.54 | 0.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 13458-144H2 |
427.25 | 171.15 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2 | 13462-144H6 |
3877.87 | 1733.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3 | 13466-144I1 |
678.76 | 312.74 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1 | 13459-144H3 |
432.91 | 216.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2 | 13463-144H7 |
382.51 | 189.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3 | 13467-144I2 |
419.93 | 207.47 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1 | 13460-144H4 |
537.02 | 463.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2 | 13464-144H8 |
549.69 | 421.99 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3 | 13468-144I3 |
380.12 | 332.97 | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
immature langerhans cells, donor1 | 11904-125F5 |
8.72 | 2.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
immature langerhans cells, donor2 | 11905-125F6 |
5.54 | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
insula, adult, pool1 | 10039-101F3 |
348.63 | 304.63 | 0.19 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
keratoacanthoma cell line:HKA-1 | 10791-110H8 |
241.91 | 91.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
kidney, adult, pool1 | 10017-101C8 |
575.73 | 839.87 | 0.60 | 0.40 | 0.60 | 0.00 | 0.00 | 0.00 |
kidney, fetal, pool1 | 10045-101F9 |
279.26 | 215.67 | 0.42 | 0.00 | 0.07 | 0.07 | 0.00 | 0.00 |
large cell lung carcinoma cell line:IA-LM | 10509-107D5 |
1395.92 | 644.63 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
large cell lung carcinoma cell line:NCI-H460 | 10839-111E2 |
479.70 | 148.06 | 0.14 | 0.69 | 0.97 | 0.28 | 0.00 | 0.00 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF | 10692-109F8 |
128.82 | 31.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
left atrium, adult, donor1 | 10079-102A7 |
293.13 | 351.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
left ventricle, adult, donor1 | 10078-102A6 |
356.49 | 615.38 | 2.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
leiomyoblastoma cell line:G-402 | 10721-110A1 |
310.00 | 174.56 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
leiomyoma cell line:10964C | 10569-108B2 |
251.83 | 153.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
leiomyoma cell line:15242A | 10570-108B3 |
242.94 | 180.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
leiomyoma cell line:15425 | 10571-108B4 |
292.59 | 180.90 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
leiomyosarcoma cell line:Hs 5.T | 10722-110A2 |
165.08 | 158.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lens epithelial cell line:SRA 01/04 | 10647-109A8 |
163.11 | 84.69 | 1.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
leukemia, chronic megakaryoblastic cell line:MEG-01 | 10752-110D5 |
753.56 | 386.99 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
liposarcoma cell line:KMLS-1 | 10782-110G8 |
318.51 | 162.61 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
liposarcoma cell line:SW 872 | 10726-110A6 |
191.53 | 120.99 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
liver, adult, pool1 | 10018-101C9 |
16.53 | 9.89 | 0.00 | 0.00 | 0.00 | 0.00 | 3.73 | 2.92 |
liver, fetal, pool1 | 10086-102B5 |
26.34 | 9.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
locus coeruleus - adult, donor10196 | 10182-103D2 |
268.61 | 330.73 | 1.46 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
locus coeruleus, adult, donor10252 | 10165-103B3 |
317.24 | 378.33 | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
locus coeruleus, adult, donor10258 | 10375-105G6 |
231.35 | 239.82 | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
locus coeruleus, newborn, donor10223 | 10362-105F2 |
276.35 | 374.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lung adenocarcinoma cell line:A549 | 10499-107C4 |
565.48 | 266.41 | 0.42 | 0.55 | 0.69 | 1.38 | 0.00 | 0.00 |
lung adenocarcinoma cell line:PC-14 | 10408-106B3 |
315.06 | 159.25 | 0.00 | 1.38 | 0.00 | 0.69 | 0.00 | 0.00 |
lung adenocarcinoma, papillary cell line:NCI-H441 | 10742-110C4 |
243.99 | 78.56 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lung, adult, pool1 | 10019-101D1 |
152.62 | 77.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lung, fetal, donor1 | 10068-101I5 |
342.77 | 205.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lung, right lower lobe, adult, donor1 | 10075-102A3 |
97.60 | 51.78 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lymph node, adult, donor1 | 10077-102A5 |
165.68 | 70.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lymphangiectasia cell line:DS-1 | 10727-110A7 |
835.94 | 191.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
lymphoma, malignant, hairy B-cell cell line:MLMA | 10775-110G1 |
654.87 | 254.16 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
malignant trichilemmal cyst cell line:DJM-1 | 10412-106B7 |
241.26 | 180.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mature adipocyte, donor1 | 12231-129F8 |
329.88 | 373.84 | 2.66 | 0.89 | 0.00 | 1.33 | 0.00 | 0.00 |
mature adipocyte, donor2 | 12232-129F9 |
357.57 | 457.81 | 4.57 | 3.11 | 2.91 | 2.08 | 0.00 | 0.00 |
mature adipocyte, donor3 | 12233-129G1 |
513.00 | 697.68 | 1.90 | 1.66 | 2.84 | 0.95 | 0.00 | 0.00 |
mature adipocyte, donor4 | 12234-129G2 |
580.13 | 604.61 | 2.37 | 0.26 | 0.79 | 0.00 | 0.00 | 0.00 |
maxillary sinus tumor cell line:HSQ-89 | 10414-106B9 |
36.93 | 9.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medial frontal gyrus - adult, donor10196 | 10170-103B8 |
307.95 | 392.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medial frontal gyrus, adult, donor10252 | 10150-102I6 |
256.55 | 348.32 | 0.92 | 0.18 | 0.00 | 0.18 | 0.00 | 0.00 |
medial frontal gyrus, adult, donor10258 | 10368-105F8 |
296.72 | 328.81 | 0.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medial frontal gyrus, newborn, donor10223 | 10352-105E1 |
452.50 | 505.39 | 0.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medial temporal gyrus - adult, donor10196 | 10183-103D3 |
383.74 | 420.86 | 0.51 | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 |
medial temporal gyrus, adult, donor10252 | 10156-103A3 |
258.07 | 353.99 | 1.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medial temporal gyrus, adult, donor10258, tech_rep1 | 10376-105G7 |
308.20 | 398.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medial temporal gyrus, adult, donor10258, tech_rep2 | 10376-105G7 |
1062.17 | 1119.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medial temporal gyrus, newborn, donor10223 | 10353-105E2 |
170.13 | 179.47 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medulla oblongata - adult, donor10196 | 10174-103C3 |
241.42 | 292.04 | 1.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medulla oblongata, adult, donor10252 | 10155-103A2 |
289.64 | 327.72 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medulla oblongata, adult, pool1 | 10038-101F2 |
346.83 | 311.24 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medulla oblongata, newborn, donor10223 | 10361-105F1 |
162.13 | 185.05 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medulloblastoma cell line:D283 Med | 10838-111E1 |
1046.39 | 652.28 | 0.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
medulloblastoma cell line:ONS-76 | 10759-110E3 |
212.88 | 154.19 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
melanoma cell line:COLO 679 | 10514-107E1 |
460.56 | 362.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
melanoma cell line:G-361 | 10465-106H6 |
352.63 | 285.04 | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
meningioma cell line:HKBMM | 10691-109F7 |
630.27 | 248.20 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
merkel cell carcinoma cell line:MKL-1 | 10843-111E6 |
545.44 | 310.17 | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
merkel cell carcinoma cell line:MS-1 | 10844-111E7 |
443.01 | 358.51 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - adipose, donor1 | 11747-123G1 |
503.57 | 295.21 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - adipose, donor2 | 11748-123G2 |
396.65 | 161.97 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - adipose, donor3 | 11749-123G3 |
417.42 | 233.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - bone marrow, donor1 | 11750-123G4 |
341.35 | 146.52 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - bone marrow, donor2 | 11751-123G5 |
326.02 | 129.21 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - bone marrow, donor3 | 11840-124H4 |
181.15 | 154.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - cardiac, donor1 | 11752-123G6 |
302.25 | 149.32 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - cardiac, donor2 | 11753-123G7 |
296.51 | 126.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - cardiac, donor3 | 11754-123G8 |
380.27 | 241.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - cardiac, donor4 | 11755-123G9 |
360.69 | 229.43 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1 | 11756-123H1 |
324.50 | 187.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2 | 11833-124G6 |
242.73 | 100.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 11760-123H5 |
345.79 | 181.82 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4 | 11836-124G9 |
269.49 | 157.44 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1 | 11758-123H3 |
259.29 | 102.29 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2 | 11835-124G8 |
183.68 | 95.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3 | 11762-123H7 |
199.14 | 69.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4 | 11838-124H2 |
129.04 | 99.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1 | 11757-123H2 |
525.71 | 394.38 | 0.00 | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 11759-123H4 |
348.49 | 180.22 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02) | 11761-123H6 |
313.18 | 149.15 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G) | 11842-124H6 |
277.96 | 110.45 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4 | 11837-124H1 |
204.32 | 122.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cell line:Hu5/E18 | 10568-108B1 |
375.12 | 268.61 | 0.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1 | 13229-141I7 |
209.61 | 115.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2 | 13230-141I8 |
257.57 | 138.12 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3 | 13231-141I9 |
248.15 | 139.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1 | 13232-142A1 |
222.13 | 124.16 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2 | 13233-142A2 |
257.01 | 138.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3 | 13234-142A3 |
238.61 | 134.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1 | 13235-142A4 |
227.14 | 113.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2 | 13236-142A5 |
219.18 | 120.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3 | 13237-142A6 |
627.95 | 144.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1 | 13238-142A7 |
292.17 | 161.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2 | 13239-142A8 |
252.33 | 121.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3 | 13240-142A9 |
246.60 | 131.71 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1 | 13241-142B1 |
255.93 | 128.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2 | 13242-142B2 |
245.37 | 124.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3 | 13243-142B3 |
220.25 | 136.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 13244-142B4 |
249.14 | 140.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 13245-142B5 |
221.49 | 125.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3 | 13246-142B6 |
216.93 | 103.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1 | 13247-142B7 |
232.55 | 123.42 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2 | 13248-142B8 |
226.98 | 100.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3 | 13249-142B9 |
230.29 | 134.87 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 13250-142C1 |
193.81 | 109.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2 | 13251-142C2 |
209.91 | 114.67 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3 | 13252-142C3 |
178.39 | 132.22 | 2.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1 | 13253-142C4 |
201.67 | 135.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2 | 13254-142C5 |
195.46 | 128.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3 | 13255-142C6 |
199.83 | 118.59 | 0.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1 | 13256-142C7 |
219.32 | 124.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2 | 13257-142C8 |
189.37 | 27.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3 | 13258-142C9 |
241.32 | 98.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1 | 13259-142D1 |
234.19 | 107.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2 | 13260-142D2 |
257.90 | 70.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3 | 13261-142D3 |
223.54 | 103.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1 | 13262-142D4 |
258.29 | 99.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2 | 13263-142D5 |
289.71 | 123.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3 | 13264-142D6 |
279.64 | 120.76 | 0.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1 | 13265-142D7 |
301.25 | 110.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2 | 13266-142D8 |
317.32 | 117.82 | 0.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3 | 13267-142D9 |
298.08 | 118.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1 | 13268-142E1 |
341.79 | 235.35 | 1.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2 | 13269-142E2 |
359.52 | 225.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3 | 13270-142E3 |
346.26 | 230.61 | 0.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1 | 13271-142E4 |
364.18 | 260.76 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2 | 13272-142E5 |
307.29 | 214.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3 | 13273-142E6 |
375.28 | 248.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1 | 13274-142E7 |
243.00 | 207.13 | 0.00 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2 | 13275-142E8 |
279.12 | 198.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3 | 13276-142E9 |
193.86 | 177.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1 | 13277-142F1 |
270.67 | 221.51 | 0.00 | 1.21 | 0.61 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2 | 13278-142F2 |
248.54 | 221.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3 | 13279-142F3 |
250.40 | 176.27 | 1.65 | 0.82 | 0.00 | 0.82 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1 | 13280-142F4 |
234.14 | 208.94 | 0.20 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2 | 13281-142F5 |
226.17 | 159.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3 | 13282-142F6 |
260.77 | 161.96 | 1.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesodermal tumor cell line:HIRS-BM | 10696-109G3 |
70.41 | 26.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:ACC-MESO-1 | 10493-107B7 |
244.27 | 56.93 | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:ACC-MESO-4 | 10494-107B8 |
99.62 | 44.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-14, tech_rep1 | 10849-111F3 |
286.33 | 243.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-14, tech_rep2 | 10849-111F3 |
398.88 | 404.94 | 0.10 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-25 | 10850-111F4 |
215.61 | 214.93 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-41 | 10851-111F5 |
381.38 | 210.49 | 0.49 | 0.24 | 0.00 | 0.49 | 0.00 | 0.00 |
mesothelioma cell line:Mero-48a | 10852-111F6 |
215.89 | 161.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-82 | 10853-111F7 |
238.89 | 168.46 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-83 | 10854-111F8 |
252.95 | 221.12 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-84 | 10855-111F9 |
306.36 | 208.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:Mero-95 | 10856-111G1 |
257.98 | 186.55 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:NCI-H2052 | 10847-111F1 |
280.77 | 198.11 | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:NCI-H226 | 10846-111E9 |
336.83 | 227.51 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:NCI-H2452 | 10848-111F2 |
418.69 | 277.07 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 |
mesothelioma cell line:NCI-H28 | 10845-111E8 |
578.91 | 482.21 | 0.51 | 0.51 | 0.76 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:No36 | 10857-111G2 |
403.51 | 367.30 | 0.65 | 0.98 | 0.65 | 0.00 | 0.00 | 0.00 |
mesothelioma cell line:ONE58 | 10858-111G3 |
279.62 | 235.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
migratory langerhans cells, donor1 | 11901-125F2 |
16.51 | 8.25 | 0.19 | 0.00 | 0.19 | 0.19 | 0.00 | 0.00 |
migratory langerhans cells, donor2 | 11902-125F3 |
8.79 | 4.52 | 0.12 | 0.12 | 0.37 | 0.49 | 0.00 | 0.00 |
migratory langerhans cells, donor3 | 11903-125F4 |
13.64 | 5.56 | 0.00 | 0.00 | 0.18 | 0.18 | 0.00 | 0.00 |
mixed mullerian tumor cell line:HTMMT | 10689-109F5 |
274.24 | 145.28 | 0.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mucinous adenocarcinoma cell line:JHOM-1 | 10648-109A9 |
149.63 | 96.01 | 8.69 | 110.84 | 71.21 | 9.33 | 0.00 | 0.00 |
mucinous cystadenocarcinoma cell line:MCAS | 10784-110H1 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 10744-110C6 |
383.82 | 123.12 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
myelodysplastic syndrome cell line:SKM-1 | 10772-110F7 |
585.79 | 387.32 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
myeloma cell line:PCM6 | 10474-106I6 |
252.82 | 104.76 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
myxofibrosarcoma cell line:MFH-ino | 10600-108E6 |
227.27 | 127.84 | 0.51 | 0.00 | 0.00 | 0.51 | 0.00 | 0.00 |
myxofibrosarcoma cell line:NMFH-1 | 10684-109E9 |
210.85 | 104.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
nasal epithelial cells, donor1, tech_rep1 | 12226-129F3 |
188.42 | 52.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
nasal epithelial cells, donor1, tech_rep2 | 12226-129F3 |
218.42 | 66.85 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
nasal epithelial cells, donor2 | 12227-129F4 |
211.96 | 50.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neuroblastoma cell line:CHP-134 | 10508-107D4 |
1080.83 | 387.88 | 1.38 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 |
neuroblastoma cell line:NB-1 | 10539-107G8 |
669.58 | 468.09 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neuroblastoma cell line:NBsusSR | 10607-108F4 |
566.66 | 323.50 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neuroblastoma cell line:NH-12 | 10555-107I6 |
1494.72 | 342.89 | 0.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neuroectodermal tumor cell line:FU-RPNT-1 | 10637-108I7 |
651.18 | 109.36 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neuroectodermal tumor cell line:FU-RPNT-2 | 10663-109C6 |
495.57 | 168.52 | 0.48 | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 |
neuroectodermal tumor cell line:TASK1 | 10774-110F9 |
1042.32 | 356.43 | 1.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neuroepithelioma cell line:SK-N-MC | 10728-110A8 |
392.27 | 185.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neurofibroma cell line:Hs 53.T | 10729-110A9 |
173.54 | 92.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neutrophil PMN, donor1 | 12133-128D9 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neutrophil PMN, donor2 | 12137-128E4 |
39.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
neutrophil PMN, donor3 | 12141-128E8 |
9.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK | 10430-106D7 |
1058.36 | 291.73 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
non-small cell lung cancer cell line:NCI-H1385 | 10730-110B1 |
523.53 | 495.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
normal embryonic palatal mesenchymal cell line:HEPM | 10813-111B3 |
245.90 | 145.56 | 0.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
normal intestinal epithelial cell line:FHs 74 Int | 10812-111B2 |
263.29 | 178.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
nucleus accumbens, adult, pool1 | 10037-101F1 |
319.28 | 287.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
occipital cortex - adult, donor10196 | 10172-103C1 |
321.42 | 447.10 | 2.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
occipital cortex, adult, donor10252 | 10163-103B1 |
281.51 | 327.67 | 3.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
occipital cortex, newborn, donor10223 | 10355-105E4 |
193.62 | 231.47 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 | 0.00 |
occipital lobe, adult, donor1 | 10076-102A4 |
306.48 | 287.85 | 1.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
occipital lobe, fetal, donor1 | 10073-102A1 |
258.75 | 87.97 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
occipital pole, adult, pool1 | 10036-101E9 |
213.98 | 168.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
olfactory region, adult | 10195-103E6 |
274.54 | 294.41 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
optic nerve, donor1 | 10277-104E7 |
86.05 | 80.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
oral squamous cell carcinoma cell line:Ca9-22 | 10434-106E2 |
320.42 | 167.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
oral squamous cell carcinoma cell line:HO-1-u-1 | 10550-107I1 |
922.00 | 495.69 | 0.00 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 |
oral squamous cell carcinoma cell line:HSC-3 | 10545-107H5 |
303.77 | 140.71 | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
oral squamous cell carcinoma cell line:SAS | 10544-107H4 |
330.35 | 64.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
osteoclastoma cell line:Hs 706.T | 10704-109H2 |
83.78 | 27.93 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
osteosarcoma cell line:143B/TK^(-)neo^(R) | 10510-107D6 |
303.66 | 131.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
osteosarcoma cell line:HS-Os-1 | 10558-107I9 |
396.97 | 268.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ovary, adult, pool1 | 10020-101D2 |
221.70 | 87.00 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pagetoid sarcoma cell line:Hs 925.T | 10732-110B3 |
156.56 | 81.76 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pancreas, adult, donor1 | 10049-101G4 |
303.83 | 137.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pancreatic carcinoma cell line:NOR-P1 | 10698-109G5 |
661.66 | 419.58 | 0.56 | 0.84 | 0.28 | 0.00 | 0.00 | 0.00 |
papillary adenocarcinoma cell line:8505C | 10437-106E5 |
354.85 | 212.09 | 0.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
papillotubular adenocarcinoma cell line:TGBC18TKB | 10417-106C3 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
paracentral gyrus, adult, pool1 | 10035-101E8 |
337.44 | 289.67 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
parietal cortex, adult, donor10258 | 10373-105G4 |
303.14 | 318.56 | 2.20 | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 |
parietal lobe - adult, donor10196 | 10171-103B9 |
278.38 | 286.85 | 2.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
parietal lobe, adult, donor10252 | 10157-103A4 |
292.45 | 371.12 | 1.14 | 0.00 | 0.00 | 0.29 | 0.00 | 0.00 |
parietal lobe, adult, pool1 | 10034-101E7 |
314.41 | 275.81 | 0.09 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
parietal lobe, fetal, donor1 | 10072-101I9 |
323.92 | 136.75 | 0.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
parietal lobe, newborn, donor10223 | 10356-105E5 |
210.11 | 232.54 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
parotid gland, adult | 10199-103F1 |
128.88 | 40.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
penis, adult | 10200-103F2 |
134.28 | 64.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
peripheral neuroectodermal tumor cell line:KU-SN | 10697-109G4 |
478.79 | 127.37 | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pharyngeal carcinoma cell line:Detroit 562 | 10723-110A3 |
287.16 | 111.02 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pineal gland - adult, donor10196 | 10179-103C8 |
170.93 | 174.80 | 0.65 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pineal gland, adult, donor10252 | 10160-103A7 |
348.22 | 300.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pineal gland, adult, donor10258 | 10377-105G8 |
222.61 | 202.55 | 1.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pituitary gland - adult, donor10196 | 10180-103C9 |
129.51 | 77.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pituitary gland, adult, donor10252 | 10162-103A9 |
176.68 | 116.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pituitary gland, adult, donor10258 | 10378-105G9 |
118.32 | 53.63 | 0.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
placenta, adult, pool1 | 10021-101D3 |
86.86 | 100.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
plasma cell leukemia cell line:ARH-77 | 10840-111E3 |
649.16 | 183.54 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pleomorphic hepatocellular carcinoma cell line:SNU-387 | 10706-109H4 |
79.84 | 47.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
pons, adult, pool1 | 10033-101E6 |
394.70 | 427.84 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 |
postcentral gyrus, adult, pool1 | 10032-101E5 |
295.00 | 249.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
promyelocytes/myelocytes PMC, donor1 | 12132-128D8 |
52.28 | 16.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
promyelocytes/myelocytes PMC, donor2 | 12136-128E3 |
495.72 | 242.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
promyelocytes/myelocytes PMC, donor3 | 12140-128E7 |
481.17 | 129.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
prostate cancer cell line:DU145 | 10490-107B4 |
396.05 | 158.63 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
prostate cancer cell line:PC-3 | 10439-106E7 |
240.49 | 138.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
prostate, adult, pool1 | 10022-101D4 |
170.41 | 72.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
putamen, adult, donor10196 | 10176-103C5 |
389.98 | 374.87 | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
putamen, adult, donor10252 | 10152-102I8 |
243.13 | 366.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
putamen, adult, donor10258, tech_rep1 | 10372-105G3 |
387.95 | 469.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
putamen, adult, donor10258, tech_rep2 | 10372-105G3 |
280.03 | 304.43 | 0.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
putamen, newborn, donor10223 | 10365-105F5 |
335.85 | 413.81 | 0.00 | 0.00 | 0.00 | 0.75 | 0.00 | 0.00 |
rectal cancer cell line:TT1TKB | 10469-106I1 |
359.89 | 109.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
rectum, fetal, donor1 | 10067-101I4 |
208.65 | 65.38 | 0.00 | 0.00 | 0.00 | 1.39 | 0.00 | 0.00 |
renal cell carcinoma cell line:OS-RC-2 | 10411-106B6 |
377.14 | 233.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
renal cell carcinoma cell line:TUHR10TKB | 10471-106I3 |
148.29 | 38.52 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
retina, adult, pool1 | 10030-101E3 |
205.36 | 100.49 | 0.10 | 0.10 | 0.00 | 0.10 | 0.00 | 0.00 |
retinoblastoma cell line:Y79 | 10475-106I7 |
1299.79 | 588.97 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
rhabdomyosarcoma cell line:KYM-1 | 10787-110H4 |
414.58 | 312.17 | 1.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
rhabdomyosarcoma cell line:RMS-YM | 10477-106I9 |
569.71 | 222.15 | 1.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
sacrococcigeal teratoma cell line:HTST | 10695-109G2 |
179.61 | 50.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
salivary acinar cells, donor1 | 11771-123I7 |
394.77 | 95.66 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
salivary acinar cells, donor2 | 11772-123I8 |
336.09 | 74.90 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
salivary acinar cells, donor3 | 11773-123I9 |
81.43 | 18.54 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
salivary gland, adult, pool1 | 10093-102C3 |
142.99 | 54.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
schwannoma cell line:HS-PSS, tech_rep1 | 10442-106F1 |
420.71 | 162.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
schwannoma cell line:HS-PSS, tech_rep2 | 10442-106F1 |
436.35 | 157.17 | 0.71 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 |
seminal vesicle, adult | 10201-103F3 |
83.59 | 28.57 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
serous adenocarcinoma cell line:JHOS-2 | 10639-108I9 |
309.24 | 155.71 | 0.24 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1 | 11843-124H7 |
174.63 | 61.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1 | 11841-124H5 |
240.85 | 186.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
serous cystadenocarcinoma cell line:HTOA | 10693-109F9 |
487.45 | 359.98 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
signet ring carcinoma cell line:Kato III | 10436-106E4 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
signet ring carcinoma cell line:NUGC-4 | 10483-107A6 |
619.32 | 286.44 | 0.13 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
skeletal muscle - soleus muscle, donor1 | 10282-104F3 |
52.49 | 36.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
skeletal muscle, adult, pool1 | 10023-101D5 |
102.19 | 78.68 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
skeletal muscle, fetal, donor1 | 10066-101I3 |
169.85 | 126.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
skin, adult, donor1 | 10074-102A2 |
54.28 | 27.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
skin, fetal, donor1 | 10065-101I2 |
151.49 | 62.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small cell cervical cancer cell line:HCSC-1 | 10800-110I8 |
603.68 | 250.81 | 1.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small cell gastrointestinal carcinoma cell line:ECC10 | 10610-108F7 |
1.89 | 2.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small cell lung carcinoma cell line:DMS 144 | 10841-111E4 |
1011.35 | 305.89 | 0.39 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
small cell lung carcinoma cell line:LK-2 | 10541-107H1 |
1031.32 | 441.41 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small cell lung carcinoma cell line:NCI-H82 | 10842-111E5 |
1311.89 | 289.21 | 1.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small cell lung carcinoma cell line:WA-hT | 10562-108A4 |
57.97 | 26.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small intestine, adult, pool1 | 10024-101D6 |
72.50 | 37.03 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small intestine, fetal, donor1 | 10064-101I1 |
171.50 | 57.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
small-cell gastrointestinal carcinoma cell line:ECC4 | 10609-108F6 |
13.85 | 5.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
smooth muscle, adult, pool1 | 10048-101G3 |
191.00 | 83.48 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
somatostatinoma cell line:QGP-1 | 10781-110G7 |
54.94 | 23.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spinal cord - adult, donor10196 | 10181-103D1 |
219.31 | 219.54 | 1.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spinal cord, adult, donor10252 | 10159-103A6 |
275.20 | 298.07 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spinal cord, adult, donor10258 | 10369-105F9 |
378.41 | 470.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spinal cord, fetal, donor1 | 10056-101H2 |
254.91 | 159.78 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spinal cord, newborn, donor10223 | 10359-105E8 |
294.36 | 302.62 | 1.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spindle cell sarcoma cell line:Hs 132.T | 10737-110B8 |
120.68 | 52.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spleen, adult, pool1 | 10025-101D7 |
148.02 | 56.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
spleen, fetal, pool1 | 10044-101F8 |
101.78 | 38.93 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
splenic lymphoma with villous lymphocytes cell line:SLVL | 10424-106D1 |
539.51 | 232.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
squamous cell carcinoma cell line:EC-GI-10 | 10463-106H4 |
287.66 | 90.00 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
squamous cell carcinoma cell line:JHUS-nk1 | 10646-109A7 |
340.37 | 220.85 | 0.35 | 2.45 | 0.35 | 0.00 | 0.00 | 0.00 |
squamous cell carcinoma cell line:T3M-5 | 10616-108G4 |
205.63 | 65.29 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
squamous cell lung carcinoma cell line:EBC-1 | 10486-107A9 |
198.67 | 132.26 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 |
squamous cell lung carcinoma cell line:LC-1F | 10457-106G7 |
63.12 | 46.60 | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 |
squamous cell lung carcinoma cell line:RERF-LC-AI | 10501-107C6 |
233.53 | 120.58 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
stomach, fetal, donor1 | 10062-101H8 |
170.88 | 51.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
submaxillary gland, adult | 10202-103F4 |
121.91 | 70.07 | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
substantia nigra - adult, donor10196 | 10178-103C7 |
217.10 | 325.64 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
substantia nigra, adult, donor10252 | 10158-103A5 |
228.06 | 255.89 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
substantia nigra, adult, donor10258 | 10371-105G2 |
370.35 | 469.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
substantia nigra, newborn, donor10223 | 10358-105E7 |
146.97 | 202.08 | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
synovial sarcoma cell line:HS-SY-II | 10441-106E9 |
707.97 | 469.99 | 1.38 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 |
temporal lobe, adult, pool1 | 10031-101E4 |
238.97 | 188.19 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
temporal lobe, fetal, donor1, tech_rep1 | 10063-101H9 |
203.00 | 60.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
temporal lobe, fetal, donor1, tech_rep2 | 10063-101H9 |
196.47 | 100.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tenocyte, donor1 | 11763-123H8 |
211.56 | 111.36 | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tenocyte, donor2 | 11765-123I1 |
194.19 | 69.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tenocyte, donor3 | 11768-123I4 |
218.32 | 95.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
teratocarcinoma cell line:NCC-IT-A3 | 10790-110H7 |
1133.98 | 888.21 | 1.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
teratocarcinoma cell line:NCR-G1 | 10798-110I6 |
846.58 | 422.06 | 0.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
teratocarcinoma cell line:PA-1 | 10807-111A6 |
613.56 | 346.07 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
testicular germ cell embryonal carcinoma cell line:ITO-II | 10786-110H3 |
1235.71 | 834.17 | 2.54 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
testicular germ cell embryonal carcinoma cell line:NEC14 | 10591-108D6 |
2254.66 | 1690.43 | 1.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
testicular germ cell embryonal carcinoma cell line:NEC15 | 10593-108D8 |
1539.20 | 786.34 | 1.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
testicular germ cell embryonal carcinoma cell line:NEC8 | 10590-108D5 |
1454.91 | 1167.32 | 1.30 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
testis, adult, pool1 | 10026-101D8 |
157.73 | 86.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
testis, adult, pool2 | 10096-102C6 |
119.09 | 70.82 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thalamus - adult, donor10196 | 10168-103B6 |
273.79 | 341.13 | 4.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thalamus, adult, donor10252 | 10154-103A1 |
259.59 | 302.09 | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thalamus, adult, donor10258, tech_rep1 | 10370-105G1 |
429.55 | 692.83 | 1.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thalamus, adult, donor10258, tech_rep2 | 10370-105G1 |
175.89 | 201.91 | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thalamus, newborn, donor10223 | 10366-105F6 |
203.66 | 285.36 | 0.58 | 0.00 | 0.58 | 0.00 | 0.00 | 0.00 |
throat, adult | 10209-103G2 |
150.55 | 134.07 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
throat, fetal, donor1 | 10061-101H7 |
167.28 | 96.90 | 0.00 | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
thymic carcinoma cell line:Ty-82 | 10803-111A2 |
613.88 | 353.74 | 0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thymus, adult, pool1 | 10027-101D9 |
384.84 | 176.56 | 0.10 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
thymus, fetal, pool1 | 10043-101F7 |
281.48 | 120.84 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thyroid carcinoma cell line:KHM-5M | 10776-110G2 |
286.53 | 183.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thyroid carcinoma cell line:TCO-1 | 10783-110G9 |
272.40 | 81.72 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
thyroid, adult, pool1 | 10028-101E1 |
246.25 | 109.83 | 0.09 | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
thyroid, fetal, donor1 | 10060-101H6 |
139.74 | 68.03 | 0.79 | 0.26 | 0.26 | 0.00 | 0.00 | 0.00 |
tongue epidermis (fungiform papillae), donor1 | 10288-104F9 |
43.11 | 36.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tongue, adult | 10203-103F5 |
220.25 | 218.39 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tongue, fetal, donor1 | 10059-101H5 |
203.35 | 164.34 | 0.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tonsil, adult, pool1 | 10047-101G2 |
188.33 | 67.92 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
trachea, adult, pool1 | 10029-101E2 |
180.20 | 97.75 | 0.16 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
trachea, fetal, donor1 | 10058-101H4 |
166.57 | 86.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
transitional cell carcinoma cell line:Hs 769.T | 10707-109H5 |
193.08 | 145.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
transitional-cell carcinoma cell line:5637 | 10418-106C4 |
268.69 | 145.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
transitional-cell carcinoma cell line:JMSU1 | 10492-107B6 |
1128.93 | 328.42 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tridermal teratoma cell line:HGRT | 10694-109G1 |
161.72 | 51.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
tubular adenocarcinoma cell line:SUIT-2 | 10797-110I5 |
602.37 | 137.13 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
umbilical cord, fetal, donor1 | 10057-101H3 |
152.31 | 104.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
uterus, adult, pool1 | 10100-102D1 |
182.06 | 72.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
uterus, fetal, donor1 | 10055-101H1 |
282.07 | 97.27 | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
vagina, adult | 10204-103F6 |
110.50 | 61.39 | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
vein, adult | 10191-103E2 |
147.96 | 61.59 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 |
xeroderma pigentosum b cell line:XPL 17 | 10563-108A5 |
608.31 | 131.12 | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |